Mental health stressors still loom for Puerto Ricans after Maria

Article Type
Changed

 

The physical and mental health needs of the people of Puerto Rico cannot be underestimated. Just think of what they have been through over the last few months.

When Hurricane Maria barreled onto the island on Sept. 20, 2017 – just 2 weeks after Hurricane Irma reportedly left more than 1 million residents without power – it ripped off roofs and left behind massive flooding, roads washed out, and utility poles and transmission lines knocked down. Whole forests were defoliated, a massive loss of flora and fauna occurred, and 80% of the crop value was destroyed, along with massive loss of stray dogs and cats, dairy cows, industrial chicken coops, and tropical birds, including endangered species. Beloved pets were displaced.

Courtesy Dr. Milner
Members of Global First Responder and the International Center for Psychosocial Trauma joined forces to assist the people of Puerto Rico after Hurricane Maria.
Hospitals lost power. Some had generators, but some of the generators had been damaged by the storm, and those that were functional could not be run 24 hours a day, for risk of destroying them. Six hospitals shut down completely and at least two operated for weeks without full power. Among these was Centro Médico, Puerto Rico’s largest medical provider, which did have power back within the week. But the power was sporadic and unreliable. Obtaining adequate supplies of diesel to operate the generators proved an ongoing problem. When the generators were running, they were polluting the air with diesel fumes, exacerbating respiratory illnesses. People on respirators could not be maintained; people in need of surgeries could not get them; dialysis patients had to be airlifted off the island – to the extent possible. Medications such as insulin could not be consistently refrigerated.

The official death toll as a result of Maria was 64 in December, but according to reporting by The New York Times, that number could be as high as 1,052. Most of the people who died reportedly were men and women over age 50 in hospitals and nursing homes suffering from illnesses such as diabetes, Alzheimer’s, kidney disease, hypertension, pneumonia, and other respiratory diseases.

One grassroots organization that mobilized to provide supplies and medical assistance was Doctoras Boricuas, a group of all-female doctors in the United States and Puerto Rico that formed after the hurricanes to coordinate the delivery and distribution of supplies directly to Puerto Rico and the Virgin Islands. Two groups affiliated with the University of Missouri at Columbia joined forces to help: Global First Responder or GFR, a nonprofit, secular international medical relief organization founded in 2011 by Adam Beckett, MD, and the International Center for Psychosocial Trauma, or ICPT, a group established in 1995 by Syed Arshad Husain, MD, to help war-traumatized children in Bosnia. I joined Dr. Husain’s group of professionals – Kathryn Dewein, PhD; Andra Ferguson, PhD; and Cathy Grigg, PsyD, – all of whom have traveled broadly in the field of disaster psychiatry – to see how we could help the people of Puerto Rico in Maria’s aftermath.
 

What we did

ICPT and GFR were a combined team, but we served different functions. As part of ICPT, I focused on the mental health component and helped to train doctors, psychologists, social workers, and other mental health workers in both San Juan and Ponce. All told, we worked with about 50 people using the model of “Training the Trainers.” Many of our students were participants in the outreach teams. Our hope is that they will be able to train their peers to recognize and alleviate symptoms of acute and chronic stress disorders. Some of the techniques taught include patient education, relaxation training, breath work, visualization techniques, mindfulness training, narrative therapy, art therapy, and other expressive techniques.

What the PMSF did

Before Maria, the Ponce Medical School Foundation was in the process of facilitating the transfer of medical records into an electronic format. After the hurricane hit, however, PMSF’s program director, Antonio Fernandez, led a shift to disaster recovery work. PMSF got involved in airlifting dialysis patients off the island to safety, provided health care, and also collaborated with the Primary Care Psychology Program at Ponce Health Services University to assist in locating patients, identifying their health needs – including mental health – and providing for those needs to the extent possible.

At the time of our visit, Puerto Rico’s network of more than 90 largely rural federally funded primary care clinics mostly had reopened, but nearly half remained on back-up generators. Even with the medical centers open, patients were not coming in for one reason or another. People had medical problems, but the daily reality of survival, obtaining food and water, took precedence. Some patients were not showing up because they had left the country, or they were in shelters without transportation. Some people did not have fuel. Some could not keep track of their appointments without cell phones and electricity allowing them to access electronic planners. Some, having been without their medications since the storms, were too sick to travel. Outreach teams were necessary to locate patients, identify their needs, and provide medical and psychological care.
 

 

 

Community outreach

Nydia M. Cappas, PsyD, director of the Primary Care Psychology Program, told us that the outreach teams – consisting of doctors or other medical professionals, social workers, and psychologists, were being sent out to communities once a week. They visited homes for the elderly, orphans’ homes, and children in foster care, as well as individual patients. A similar service was provided by Vargas Medicine (VARMED) in the San Juan area.

Team members found that many people were suffering symptoms of posttraumatic stress disorder, even people who did not have prior psychiatric symptoms. They were having flashbacks and nightmares. Those flashbacks and nightmares were being triggered by clouds, by rain, by supplies beginning to run out.

Dr. Judith R. Milner
Some people were avoiding taking their medications and socializing with others, and were experiencing anhedonia. People were experiencing affect dyscontrol, anger, irritability, impatience, intolerance.

Another trend we observed is that terrain changes prompted by Maria triggered PTSD symptoms among many veterans. The defoliated trees and brown earth were causing them to have flashbacks to the deserts of Afghanistan and Iraq. Children were showing regressive behaviors, loss of developmental milestones, and symptoms of separation anxiety such as wanting to sleep with their parents. In severe cases, they were having psychotic symptoms and auditory hallucinations. The children were grieving the loss of their homes, toys, pets, and family members, in some cases. The teams were able to provide psychological first aid, help people fill out their forms for Federal Emergency Management Agency relief, and distribute medical supplies, including medications, food, toiletries, and other household goods.
 

Puerto Rico’s future

Two and a half months after Maria, we learned from our students that things gradually had begun to improve. For example, the public schools had just reopened, and that change was expected to have a stabilizing effect on the children. We also learned that, of the 80 shelters that had been set up housing about 12,500 people, 40 shelters had closed. The five medical shelters that had been set up and funded by FEMA also were in the process of closing, and private donations were beginning to slow down. People were slowly returning to their tarped or otherwise repaired homes, albeit all too often without power.

During the storm, nearly 500,000* homes were destroyed. FEMA offered to airlift about 3,000 people who had no home 2 months past Maria to the U.S. mainland – either Florida or New York.

According to our students, people living in the mountains, mainly coffee growers and retired people and comprising about one-third of the population, remain in acute crisis. Part of the challenge is being able to reach this population: Some roads are still impassable, and supplies – such as drinking water – can be delivered only by helicopter. Despite current conditions, FEMA reportedly has announced that it would end emergency operations on the island.

Our team is currently involved in applying for grant funding that will enable us to return to provide additional training to physicians’ and teachers’ groups. Over the course of the next year, we would like to make six trips to Puerto Rico and focus each trip on a different region and different group of professionals so that the entire island has resources. In addition, we will offer follow-up consultations to professionals we trained previously. The regions to be trained would be San Juan, Ponce, Utuado, Mayagüez, Guayama, and a sixth to be determined upon need. We also would like to address the needs of any ongoing relief workers so that they will be more effective in their ongoing role. Meanwhile, financial assistance from the mainland remains uneven.

Many months after Maria (and Irma), the physical and mental health needs of the Puerto Rican people remain great. However, as mental health professionals, we have the tools to help them move forward.
 

Judith R. Milner, MD, MEd, SpecEd, is a general, child, and adolescent psychiatrist in private practice in Everett, Wash. She has traveled with various groups over the years in an effort to alleviate some of the suffering caused by war and natural disaster. Her predominant association has been with the International Center for Psychosocial Trauma. She also has worked with Step Up Rwanda Women and Pygmy Survival Alliance, as well as on the Committee for Women at the American Psychiatric Association and the Consumer Issues Committee and Membership Committee for the American Academy of Child and Adolescent Psychiatry.

*Correction, 2/12/2018: An earlier version of this story misstated the number of homes reportedly destroyed by Hurricane Maria.

 

Publications
Topics
Sections

 

The physical and mental health needs of the people of Puerto Rico cannot be underestimated. Just think of what they have been through over the last few months.

When Hurricane Maria barreled onto the island on Sept. 20, 2017 – just 2 weeks after Hurricane Irma reportedly left more than 1 million residents without power – it ripped off roofs and left behind massive flooding, roads washed out, and utility poles and transmission lines knocked down. Whole forests were defoliated, a massive loss of flora and fauna occurred, and 80% of the crop value was destroyed, along with massive loss of stray dogs and cats, dairy cows, industrial chicken coops, and tropical birds, including endangered species. Beloved pets were displaced.

Courtesy Dr. Milner
Members of Global First Responder and the International Center for Psychosocial Trauma joined forces to assist the people of Puerto Rico after Hurricane Maria.
Hospitals lost power. Some had generators, but some of the generators had been damaged by the storm, and those that were functional could not be run 24 hours a day, for risk of destroying them. Six hospitals shut down completely and at least two operated for weeks without full power. Among these was Centro Médico, Puerto Rico’s largest medical provider, which did have power back within the week. But the power was sporadic and unreliable. Obtaining adequate supplies of diesel to operate the generators proved an ongoing problem. When the generators were running, they were polluting the air with diesel fumes, exacerbating respiratory illnesses. People on respirators could not be maintained; people in need of surgeries could not get them; dialysis patients had to be airlifted off the island – to the extent possible. Medications such as insulin could not be consistently refrigerated.

The official death toll as a result of Maria was 64 in December, but according to reporting by The New York Times, that number could be as high as 1,052. Most of the people who died reportedly were men and women over age 50 in hospitals and nursing homes suffering from illnesses such as diabetes, Alzheimer’s, kidney disease, hypertension, pneumonia, and other respiratory diseases.

One grassroots organization that mobilized to provide supplies and medical assistance was Doctoras Boricuas, a group of all-female doctors in the United States and Puerto Rico that formed after the hurricanes to coordinate the delivery and distribution of supplies directly to Puerto Rico and the Virgin Islands. Two groups affiliated with the University of Missouri at Columbia joined forces to help: Global First Responder or GFR, a nonprofit, secular international medical relief organization founded in 2011 by Adam Beckett, MD, and the International Center for Psychosocial Trauma, or ICPT, a group established in 1995 by Syed Arshad Husain, MD, to help war-traumatized children in Bosnia. I joined Dr. Husain’s group of professionals – Kathryn Dewein, PhD; Andra Ferguson, PhD; and Cathy Grigg, PsyD, – all of whom have traveled broadly in the field of disaster psychiatry – to see how we could help the people of Puerto Rico in Maria’s aftermath.
 

What we did

ICPT and GFR were a combined team, but we served different functions. As part of ICPT, I focused on the mental health component and helped to train doctors, psychologists, social workers, and other mental health workers in both San Juan and Ponce. All told, we worked with about 50 people using the model of “Training the Trainers.” Many of our students were participants in the outreach teams. Our hope is that they will be able to train their peers to recognize and alleviate symptoms of acute and chronic stress disorders. Some of the techniques taught include patient education, relaxation training, breath work, visualization techniques, mindfulness training, narrative therapy, art therapy, and other expressive techniques.

What the PMSF did

Before Maria, the Ponce Medical School Foundation was in the process of facilitating the transfer of medical records into an electronic format. After the hurricane hit, however, PMSF’s program director, Antonio Fernandez, led a shift to disaster recovery work. PMSF got involved in airlifting dialysis patients off the island to safety, provided health care, and also collaborated with the Primary Care Psychology Program at Ponce Health Services University to assist in locating patients, identifying their health needs – including mental health – and providing for those needs to the extent possible.

At the time of our visit, Puerto Rico’s network of more than 90 largely rural federally funded primary care clinics mostly had reopened, but nearly half remained on back-up generators. Even with the medical centers open, patients were not coming in for one reason or another. People had medical problems, but the daily reality of survival, obtaining food and water, took precedence. Some patients were not showing up because they had left the country, or they were in shelters without transportation. Some people did not have fuel. Some could not keep track of their appointments without cell phones and electricity allowing them to access electronic planners. Some, having been without their medications since the storms, were too sick to travel. Outreach teams were necessary to locate patients, identify their needs, and provide medical and psychological care.
 

 

 

Community outreach

Nydia M. Cappas, PsyD, director of the Primary Care Psychology Program, told us that the outreach teams – consisting of doctors or other medical professionals, social workers, and psychologists, were being sent out to communities once a week. They visited homes for the elderly, orphans’ homes, and children in foster care, as well as individual patients. A similar service was provided by Vargas Medicine (VARMED) in the San Juan area.

Team members found that many people were suffering symptoms of posttraumatic stress disorder, even people who did not have prior psychiatric symptoms. They were having flashbacks and nightmares. Those flashbacks and nightmares were being triggered by clouds, by rain, by supplies beginning to run out.

Dr. Judith R. Milner
Some people were avoiding taking their medications and socializing with others, and were experiencing anhedonia. People were experiencing affect dyscontrol, anger, irritability, impatience, intolerance.

Another trend we observed is that terrain changes prompted by Maria triggered PTSD symptoms among many veterans. The defoliated trees and brown earth were causing them to have flashbacks to the deserts of Afghanistan and Iraq. Children were showing regressive behaviors, loss of developmental milestones, and symptoms of separation anxiety such as wanting to sleep with their parents. In severe cases, they were having psychotic symptoms and auditory hallucinations. The children were grieving the loss of their homes, toys, pets, and family members, in some cases. The teams were able to provide psychological first aid, help people fill out their forms for Federal Emergency Management Agency relief, and distribute medical supplies, including medications, food, toiletries, and other household goods.
 

Puerto Rico’s future

Two and a half months after Maria, we learned from our students that things gradually had begun to improve. For example, the public schools had just reopened, and that change was expected to have a stabilizing effect on the children. We also learned that, of the 80 shelters that had been set up housing about 12,500 people, 40 shelters had closed. The five medical shelters that had been set up and funded by FEMA also were in the process of closing, and private donations were beginning to slow down. People were slowly returning to their tarped or otherwise repaired homes, albeit all too often without power.

During the storm, nearly 500,000* homes were destroyed. FEMA offered to airlift about 3,000 people who had no home 2 months past Maria to the U.S. mainland – either Florida or New York.

According to our students, people living in the mountains, mainly coffee growers and retired people and comprising about one-third of the population, remain in acute crisis. Part of the challenge is being able to reach this population: Some roads are still impassable, and supplies – such as drinking water – can be delivered only by helicopter. Despite current conditions, FEMA reportedly has announced that it would end emergency operations on the island.

Our team is currently involved in applying for grant funding that will enable us to return to provide additional training to physicians’ and teachers’ groups. Over the course of the next year, we would like to make six trips to Puerto Rico and focus each trip on a different region and different group of professionals so that the entire island has resources. In addition, we will offer follow-up consultations to professionals we trained previously. The regions to be trained would be San Juan, Ponce, Utuado, Mayagüez, Guayama, and a sixth to be determined upon need. We also would like to address the needs of any ongoing relief workers so that they will be more effective in their ongoing role. Meanwhile, financial assistance from the mainland remains uneven.

Many months after Maria (and Irma), the physical and mental health needs of the Puerto Rican people remain great. However, as mental health professionals, we have the tools to help them move forward.
 

Judith R. Milner, MD, MEd, SpecEd, is a general, child, and adolescent psychiatrist in private practice in Everett, Wash. She has traveled with various groups over the years in an effort to alleviate some of the suffering caused by war and natural disaster. Her predominant association has been with the International Center for Psychosocial Trauma. She also has worked with Step Up Rwanda Women and Pygmy Survival Alliance, as well as on the Committee for Women at the American Psychiatric Association and the Consumer Issues Committee and Membership Committee for the American Academy of Child and Adolescent Psychiatry.

*Correction, 2/12/2018: An earlier version of this story misstated the number of homes reportedly destroyed by Hurricane Maria.

 

 

The physical and mental health needs of the people of Puerto Rico cannot be underestimated. Just think of what they have been through over the last few months.

When Hurricane Maria barreled onto the island on Sept. 20, 2017 – just 2 weeks after Hurricane Irma reportedly left more than 1 million residents without power – it ripped off roofs and left behind massive flooding, roads washed out, and utility poles and transmission lines knocked down. Whole forests were defoliated, a massive loss of flora and fauna occurred, and 80% of the crop value was destroyed, along with massive loss of stray dogs and cats, dairy cows, industrial chicken coops, and tropical birds, including endangered species. Beloved pets were displaced.

Courtesy Dr. Milner
Members of Global First Responder and the International Center for Psychosocial Trauma joined forces to assist the people of Puerto Rico after Hurricane Maria.
Hospitals lost power. Some had generators, but some of the generators had been damaged by the storm, and those that were functional could not be run 24 hours a day, for risk of destroying them. Six hospitals shut down completely and at least two operated for weeks without full power. Among these was Centro Médico, Puerto Rico’s largest medical provider, which did have power back within the week. But the power was sporadic and unreliable. Obtaining adequate supplies of diesel to operate the generators proved an ongoing problem. When the generators were running, they were polluting the air with diesel fumes, exacerbating respiratory illnesses. People on respirators could not be maintained; people in need of surgeries could not get them; dialysis patients had to be airlifted off the island – to the extent possible. Medications such as insulin could not be consistently refrigerated.

The official death toll as a result of Maria was 64 in December, but according to reporting by The New York Times, that number could be as high as 1,052. Most of the people who died reportedly were men and women over age 50 in hospitals and nursing homes suffering from illnesses such as diabetes, Alzheimer’s, kidney disease, hypertension, pneumonia, and other respiratory diseases.

One grassroots organization that mobilized to provide supplies and medical assistance was Doctoras Boricuas, a group of all-female doctors in the United States and Puerto Rico that formed after the hurricanes to coordinate the delivery and distribution of supplies directly to Puerto Rico and the Virgin Islands. Two groups affiliated with the University of Missouri at Columbia joined forces to help: Global First Responder or GFR, a nonprofit, secular international medical relief organization founded in 2011 by Adam Beckett, MD, and the International Center for Psychosocial Trauma, or ICPT, a group established in 1995 by Syed Arshad Husain, MD, to help war-traumatized children in Bosnia. I joined Dr. Husain’s group of professionals – Kathryn Dewein, PhD; Andra Ferguson, PhD; and Cathy Grigg, PsyD, – all of whom have traveled broadly in the field of disaster psychiatry – to see how we could help the people of Puerto Rico in Maria’s aftermath.
 

What we did

ICPT and GFR were a combined team, but we served different functions. As part of ICPT, I focused on the mental health component and helped to train doctors, psychologists, social workers, and other mental health workers in both San Juan and Ponce. All told, we worked with about 50 people using the model of “Training the Trainers.” Many of our students were participants in the outreach teams. Our hope is that they will be able to train their peers to recognize and alleviate symptoms of acute and chronic stress disorders. Some of the techniques taught include patient education, relaxation training, breath work, visualization techniques, mindfulness training, narrative therapy, art therapy, and other expressive techniques.

What the PMSF did

Before Maria, the Ponce Medical School Foundation was in the process of facilitating the transfer of medical records into an electronic format. After the hurricane hit, however, PMSF’s program director, Antonio Fernandez, led a shift to disaster recovery work. PMSF got involved in airlifting dialysis patients off the island to safety, provided health care, and also collaborated with the Primary Care Psychology Program at Ponce Health Services University to assist in locating patients, identifying their health needs – including mental health – and providing for those needs to the extent possible.

At the time of our visit, Puerto Rico’s network of more than 90 largely rural federally funded primary care clinics mostly had reopened, but nearly half remained on back-up generators. Even with the medical centers open, patients were not coming in for one reason or another. People had medical problems, but the daily reality of survival, obtaining food and water, took precedence. Some patients were not showing up because they had left the country, or they were in shelters without transportation. Some people did not have fuel. Some could not keep track of their appointments without cell phones and electricity allowing them to access electronic planners. Some, having been without their medications since the storms, were too sick to travel. Outreach teams were necessary to locate patients, identify their needs, and provide medical and psychological care.
 

 

 

Community outreach

Nydia M. Cappas, PsyD, director of the Primary Care Psychology Program, told us that the outreach teams – consisting of doctors or other medical professionals, social workers, and psychologists, were being sent out to communities once a week. They visited homes for the elderly, orphans’ homes, and children in foster care, as well as individual patients. A similar service was provided by Vargas Medicine (VARMED) in the San Juan area.

Team members found that many people were suffering symptoms of posttraumatic stress disorder, even people who did not have prior psychiatric symptoms. They were having flashbacks and nightmares. Those flashbacks and nightmares were being triggered by clouds, by rain, by supplies beginning to run out.

Dr. Judith R. Milner
Some people were avoiding taking their medications and socializing with others, and were experiencing anhedonia. People were experiencing affect dyscontrol, anger, irritability, impatience, intolerance.

Another trend we observed is that terrain changes prompted by Maria triggered PTSD symptoms among many veterans. The defoliated trees and brown earth were causing them to have flashbacks to the deserts of Afghanistan and Iraq. Children were showing regressive behaviors, loss of developmental milestones, and symptoms of separation anxiety such as wanting to sleep with their parents. In severe cases, they were having psychotic symptoms and auditory hallucinations. The children were grieving the loss of their homes, toys, pets, and family members, in some cases. The teams were able to provide psychological first aid, help people fill out their forms for Federal Emergency Management Agency relief, and distribute medical supplies, including medications, food, toiletries, and other household goods.
 

Puerto Rico’s future

Two and a half months after Maria, we learned from our students that things gradually had begun to improve. For example, the public schools had just reopened, and that change was expected to have a stabilizing effect on the children. We also learned that, of the 80 shelters that had been set up housing about 12,500 people, 40 shelters had closed. The five medical shelters that had been set up and funded by FEMA also were in the process of closing, and private donations were beginning to slow down. People were slowly returning to their tarped or otherwise repaired homes, albeit all too often without power.

During the storm, nearly 500,000* homes were destroyed. FEMA offered to airlift about 3,000 people who had no home 2 months past Maria to the U.S. mainland – either Florida or New York.

According to our students, people living in the mountains, mainly coffee growers and retired people and comprising about one-third of the population, remain in acute crisis. Part of the challenge is being able to reach this population: Some roads are still impassable, and supplies – such as drinking water – can be delivered only by helicopter. Despite current conditions, FEMA reportedly has announced that it would end emergency operations on the island.

Our team is currently involved in applying for grant funding that will enable us to return to provide additional training to physicians’ and teachers’ groups. Over the course of the next year, we would like to make six trips to Puerto Rico and focus each trip on a different region and different group of professionals so that the entire island has resources. In addition, we will offer follow-up consultations to professionals we trained previously. The regions to be trained would be San Juan, Ponce, Utuado, Mayagüez, Guayama, and a sixth to be determined upon need. We also would like to address the needs of any ongoing relief workers so that they will be more effective in their ongoing role. Meanwhile, financial assistance from the mainland remains uneven.

Many months after Maria (and Irma), the physical and mental health needs of the Puerto Rican people remain great. However, as mental health professionals, we have the tools to help them move forward.
 

Judith R. Milner, MD, MEd, SpecEd, is a general, child, and adolescent psychiatrist in private practice in Everett, Wash. She has traveled with various groups over the years in an effort to alleviate some of the suffering caused by war and natural disaster. Her predominant association has been with the International Center for Psychosocial Trauma. She also has worked with Step Up Rwanda Women and Pygmy Survival Alliance, as well as on the Committee for Women at the American Psychiatric Association and the Consumer Issues Committee and Membership Committee for the American Academy of Child and Adolescent Psychiatry.

*Correction, 2/12/2018: An earlier version of this story misstated the number of homes reportedly destroyed by Hurricane Maria.

 

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default

VIDEO: Cystic fibrosis patients need earlier, more frequent colorectal cancer screening

Susan Millard, MD, FCCP, comments on Cystic Fibrosis
Article Type
Changed

 

Adults with cystic fibrosis (CF) should undergo screening colonoscopy for colorectal cancer every 5 years beginning at age 40 years, unless they have had a solid organ transplant – in which case, screening should begin at age 30 years. For both groups, screening intervals should be shortened to 3 years if any adenomatous polyps are recovered.

The new screening recommendation is 1 of 10 set forth by the Cystic Fibrosis Foundation, in conjunction with the American Gastroenterological Association. The document reflects the significantly increased risk of colorectal cancer among adults with the chronic lung disorder, Denis Hadjiliadis, MD, and his colleagues wrote in the February issue of Gastroenterology. CF patients face up to a 10-fold risk of colorectal cancer, compared with the general population; the risk approaches a 30-fold increase among CF patients who have undergone a lung transplant.

SOURCE: American Gastroenterological Association

In addition to making recommendations on screening intervals and protocols, the document asks clinicians to reframe their thinking of CF as a respiratory-only disease.

“Physicians should recognize that CF is a colon cancer syndrome,” wrote Dr. Hadjiliadis, director of the Adult Cystic Fibrosis Program at the University of Pennsylvania, Philadelphia, and his coauthors.

The increased colorectal cancer risk has become increasingly evident as CF patients live longer, Dr. Hadjiliadis and the panel wrote.

“The current median predicted survival is 41 years, and persons born in 2015 have an estimated average life expectancy of 45 years. The increasing longevity of adults with CF puts them at risk for other diseases, such as gastrointestinal cancer.”

In addition to the normal age-related risk, however, CF patients seem to have an elevated risk profile unique to the disease. The underlying causes have not been fully elucidated but may have to do with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), which are responsible for the excess thickened mucosal secretions that characterize CF. CFTR also is a tumor-suppressor gene in the intestinal tract of mice, and is important in gastrointestinal epithelial homeostasis. “Absence of CFTR is associated with dysregulation of the immune response, intestinal stem cells, and growth signaling regulators,” the authors noted.

In response to this observed increased risk of colorectal cancers among CF patients, the Cystic Fibrosis Foundation convened an 18-member task force to review the extant literature and compile colorectal cancer screening recommendations for CF patients who show no signs of such malignancies. The team reviewed 1,159 articles and based its findings on the 50 most relevant. The papers comprised observational studies, case-control studies, and case reports; there are no randomized clinical trials of screening for this population.

The American Gastroenterological Association reviewed and approved all of the recommendations:

  • Screening decisions should be a collaborative process between the CF patient and clinician, taking into account comorbidities, safety, and quality of life. This should include a discussion of expected lifespan; patients with limited lifespan won’t benefit from screening for a slow-growing cancer. Patients should also consider that the colonoscopy prep for CF patients is somewhat more complex than for non-CF patients. “Given these complexities, the task force agreed that individuals with CF and their providers should … carefully assess the risks and benefits of CRC screening and its impact on the health and quality of life for the adult with CF.”
  • The decision team should include an endoscopist. An endoscopist with CF training is preferred, but the panel noted these specialists are rare.
  • Colonoscopy is the preferred method of screening for CF patients, since it can both detect and remove polyps. “This is one of the main reasons why colonoscopy is the screening procedure of choice for other high-risk groups,” the panel noted.
  • There is insufficient evidence to recommend alternate screening methods in CF patients, including CT scanning, colonography, stool-based tests, or flexible sigmoidoscopy.
  • In CF patients without signs of CRC, screening should commence at age 40 years and be repeated every 5 years as long as the results are negative.
  • Any CF patient who has had adenomatous polyps on a screening colonoscopy should have a repeat colonoscopy within 3 years, unless clinical findings support more frequent screening.
  • For any adult CF patient older than age 30 years who has undergone a solid organ transplant, screening colonoscopy should commence within 2 years of transplantation. “Although the absolute risk of CRC in individuals with CF is extremely low for patients younger than 30 years, the risk … greatly increases after lung transplantation,” to 25-30 times the age-adjusted baseline, the panel wrote. “Increased posttransplantation survival means that many transplant patients will enter older age groups where there is an increased risk of cancer.” Screening should be performed after recovery and within 2 years, unless there was a negative colonoscopy in the 5 years before transplant.
  • Thereafter, patients who have had a solid organ transplant should undergo colonoscopy every 5 years, based on their life expectancy. “In cases where the expected survival time is limited (less than 10 years), screening should not be performed. For adults appropriately selected, lung transplantation usually increases survival probability. Therefore, a lung transplantation candidate with a short life expectancy is likely to become a screening candidate before and after transplantation at the appropriate ages described here, because the potential survival increases to approximately 10 years.”
  • Colonoscopy should be repeated every 3 years on CF patients with transplants with a history of adenomatous polyps. This interval may be as short as 1 year for patients with high-risk, large, or multiple polyps.
  • CF patients should undergo more intense bowel prep for colonoscopy, with three-four washes of a minimum of one liter of purgative per wash; the last wash should occur 4-6 hours before the procedure. Split-prep regimens (several smaller-volume washes) are better than a single larger-volume wash. The panel suggested a sample CF-specific regimen available from the Minnesota Cystic Fibrosis Center.
 

 

The new document reflects expert consensus on the currently available data, the panel said. As more data emerge, the recommendations might change.

“It is possible that different subpopulations will need more or less frequent schedules for rescreening and surveillance. Our recommendations are making an effort to balance the risk of missing advanced colorectal cancer and minimizing the burden and risk of too frequent examinations.”

None of the panel members had any financial disclosures.

SOURCE: Hadjiliadis D et al. Gastroenterology. 2017 Dec 28. doi. org/10.1053/j.gastro.2017.12.012

Body

According to the Cystic Fibrosis Foundation Patient Registry, more than 30,000 people are living with cystic fibrosis (CF ) in the United States. More than half of the CF population is over 18 years of age! It is extremely important to talk to patients about preventative medicine which was not a topic of conversation CF healthcare providers were adding to their management plan in the past. 

Dr. Susan Millard
Publications
Topics
Sections
Body

According to the Cystic Fibrosis Foundation Patient Registry, more than 30,000 people are living with cystic fibrosis (CF ) in the United States. More than half of the CF population is over 18 years of age! It is extremely important to talk to patients about preventative medicine which was not a topic of conversation CF healthcare providers were adding to their management plan in the past. 

Dr. Susan Millard
Body

According to the Cystic Fibrosis Foundation Patient Registry, more than 30,000 people are living with cystic fibrosis (CF ) in the United States. More than half of the CF population is over 18 years of age! It is extremely important to talk to patients about preventative medicine which was not a topic of conversation CF healthcare providers were adding to their management plan in the past. 

Dr. Susan Millard
Title
Susan Millard, MD, FCCP, comments on Cystic Fibrosis
Susan Millard, MD, FCCP, comments on Cystic Fibrosis

 

Adults with cystic fibrosis (CF) should undergo screening colonoscopy for colorectal cancer every 5 years beginning at age 40 years, unless they have had a solid organ transplant – in which case, screening should begin at age 30 years. For both groups, screening intervals should be shortened to 3 years if any adenomatous polyps are recovered.

The new screening recommendation is 1 of 10 set forth by the Cystic Fibrosis Foundation, in conjunction with the American Gastroenterological Association. The document reflects the significantly increased risk of colorectal cancer among adults with the chronic lung disorder, Denis Hadjiliadis, MD, and his colleagues wrote in the February issue of Gastroenterology. CF patients face up to a 10-fold risk of colorectal cancer, compared with the general population; the risk approaches a 30-fold increase among CF patients who have undergone a lung transplant.

SOURCE: American Gastroenterological Association

In addition to making recommendations on screening intervals and protocols, the document asks clinicians to reframe their thinking of CF as a respiratory-only disease.

“Physicians should recognize that CF is a colon cancer syndrome,” wrote Dr. Hadjiliadis, director of the Adult Cystic Fibrosis Program at the University of Pennsylvania, Philadelphia, and his coauthors.

The increased colorectal cancer risk has become increasingly evident as CF patients live longer, Dr. Hadjiliadis and the panel wrote.

“The current median predicted survival is 41 years, and persons born in 2015 have an estimated average life expectancy of 45 years. The increasing longevity of adults with CF puts them at risk for other diseases, such as gastrointestinal cancer.”

In addition to the normal age-related risk, however, CF patients seem to have an elevated risk profile unique to the disease. The underlying causes have not been fully elucidated but may have to do with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), which are responsible for the excess thickened mucosal secretions that characterize CF. CFTR also is a tumor-suppressor gene in the intestinal tract of mice, and is important in gastrointestinal epithelial homeostasis. “Absence of CFTR is associated with dysregulation of the immune response, intestinal stem cells, and growth signaling regulators,” the authors noted.

In response to this observed increased risk of colorectal cancers among CF patients, the Cystic Fibrosis Foundation convened an 18-member task force to review the extant literature and compile colorectal cancer screening recommendations for CF patients who show no signs of such malignancies. The team reviewed 1,159 articles and based its findings on the 50 most relevant. The papers comprised observational studies, case-control studies, and case reports; there are no randomized clinical trials of screening for this population.

The American Gastroenterological Association reviewed and approved all of the recommendations:

  • Screening decisions should be a collaborative process between the CF patient and clinician, taking into account comorbidities, safety, and quality of life. This should include a discussion of expected lifespan; patients with limited lifespan won’t benefit from screening for a slow-growing cancer. Patients should also consider that the colonoscopy prep for CF patients is somewhat more complex than for non-CF patients. “Given these complexities, the task force agreed that individuals with CF and their providers should … carefully assess the risks and benefits of CRC screening and its impact on the health and quality of life for the adult with CF.”
  • The decision team should include an endoscopist. An endoscopist with CF training is preferred, but the panel noted these specialists are rare.
  • Colonoscopy is the preferred method of screening for CF patients, since it can both detect and remove polyps. “This is one of the main reasons why colonoscopy is the screening procedure of choice for other high-risk groups,” the panel noted.
  • There is insufficient evidence to recommend alternate screening methods in CF patients, including CT scanning, colonography, stool-based tests, or flexible sigmoidoscopy.
  • In CF patients without signs of CRC, screening should commence at age 40 years and be repeated every 5 years as long as the results are negative.
  • Any CF patient who has had adenomatous polyps on a screening colonoscopy should have a repeat colonoscopy within 3 years, unless clinical findings support more frequent screening.
  • For any adult CF patient older than age 30 years who has undergone a solid organ transplant, screening colonoscopy should commence within 2 years of transplantation. “Although the absolute risk of CRC in individuals with CF is extremely low for patients younger than 30 years, the risk … greatly increases after lung transplantation,” to 25-30 times the age-adjusted baseline, the panel wrote. “Increased posttransplantation survival means that many transplant patients will enter older age groups where there is an increased risk of cancer.” Screening should be performed after recovery and within 2 years, unless there was a negative colonoscopy in the 5 years before transplant.
  • Thereafter, patients who have had a solid organ transplant should undergo colonoscopy every 5 years, based on their life expectancy. “In cases where the expected survival time is limited (less than 10 years), screening should not be performed. For adults appropriately selected, lung transplantation usually increases survival probability. Therefore, a lung transplantation candidate with a short life expectancy is likely to become a screening candidate before and after transplantation at the appropriate ages described here, because the potential survival increases to approximately 10 years.”
  • Colonoscopy should be repeated every 3 years on CF patients with transplants with a history of adenomatous polyps. This interval may be as short as 1 year for patients with high-risk, large, or multiple polyps.
  • CF patients should undergo more intense bowel prep for colonoscopy, with three-four washes of a minimum of one liter of purgative per wash; the last wash should occur 4-6 hours before the procedure. Split-prep regimens (several smaller-volume washes) are better than a single larger-volume wash. The panel suggested a sample CF-specific regimen available from the Minnesota Cystic Fibrosis Center.
 

 

The new document reflects expert consensus on the currently available data, the panel said. As more data emerge, the recommendations might change.

“It is possible that different subpopulations will need more or less frequent schedules for rescreening and surveillance. Our recommendations are making an effort to balance the risk of missing advanced colorectal cancer and minimizing the burden and risk of too frequent examinations.”

None of the panel members had any financial disclosures.

SOURCE: Hadjiliadis D et al. Gastroenterology. 2017 Dec 28. doi. org/10.1053/j.gastro.2017.12.012

 

Adults with cystic fibrosis (CF) should undergo screening colonoscopy for colorectal cancer every 5 years beginning at age 40 years, unless they have had a solid organ transplant – in which case, screening should begin at age 30 years. For both groups, screening intervals should be shortened to 3 years if any adenomatous polyps are recovered.

The new screening recommendation is 1 of 10 set forth by the Cystic Fibrosis Foundation, in conjunction with the American Gastroenterological Association. The document reflects the significantly increased risk of colorectal cancer among adults with the chronic lung disorder, Denis Hadjiliadis, MD, and his colleagues wrote in the February issue of Gastroenterology. CF patients face up to a 10-fold risk of colorectal cancer, compared with the general population; the risk approaches a 30-fold increase among CF patients who have undergone a lung transplant.

SOURCE: American Gastroenterological Association

In addition to making recommendations on screening intervals and protocols, the document asks clinicians to reframe their thinking of CF as a respiratory-only disease.

“Physicians should recognize that CF is a colon cancer syndrome,” wrote Dr. Hadjiliadis, director of the Adult Cystic Fibrosis Program at the University of Pennsylvania, Philadelphia, and his coauthors.

The increased colorectal cancer risk has become increasingly evident as CF patients live longer, Dr. Hadjiliadis and the panel wrote.

“The current median predicted survival is 41 years, and persons born in 2015 have an estimated average life expectancy of 45 years. The increasing longevity of adults with CF puts them at risk for other diseases, such as gastrointestinal cancer.”

In addition to the normal age-related risk, however, CF patients seem to have an elevated risk profile unique to the disease. The underlying causes have not been fully elucidated but may have to do with mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), which are responsible for the excess thickened mucosal secretions that characterize CF. CFTR also is a tumor-suppressor gene in the intestinal tract of mice, and is important in gastrointestinal epithelial homeostasis. “Absence of CFTR is associated with dysregulation of the immune response, intestinal stem cells, and growth signaling regulators,” the authors noted.

In response to this observed increased risk of colorectal cancers among CF patients, the Cystic Fibrosis Foundation convened an 18-member task force to review the extant literature and compile colorectal cancer screening recommendations for CF patients who show no signs of such malignancies. The team reviewed 1,159 articles and based its findings on the 50 most relevant. The papers comprised observational studies, case-control studies, and case reports; there are no randomized clinical trials of screening for this population.

The American Gastroenterological Association reviewed and approved all of the recommendations:

  • Screening decisions should be a collaborative process between the CF patient and clinician, taking into account comorbidities, safety, and quality of life. This should include a discussion of expected lifespan; patients with limited lifespan won’t benefit from screening for a slow-growing cancer. Patients should also consider that the colonoscopy prep for CF patients is somewhat more complex than for non-CF patients. “Given these complexities, the task force agreed that individuals with CF and their providers should … carefully assess the risks and benefits of CRC screening and its impact on the health and quality of life for the adult with CF.”
  • The decision team should include an endoscopist. An endoscopist with CF training is preferred, but the panel noted these specialists are rare.
  • Colonoscopy is the preferred method of screening for CF patients, since it can both detect and remove polyps. “This is one of the main reasons why colonoscopy is the screening procedure of choice for other high-risk groups,” the panel noted.
  • There is insufficient evidence to recommend alternate screening methods in CF patients, including CT scanning, colonography, stool-based tests, or flexible sigmoidoscopy.
  • In CF patients without signs of CRC, screening should commence at age 40 years and be repeated every 5 years as long as the results are negative.
  • Any CF patient who has had adenomatous polyps on a screening colonoscopy should have a repeat colonoscopy within 3 years, unless clinical findings support more frequent screening.
  • For any adult CF patient older than age 30 years who has undergone a solid organ transplant, screening colonoscopy should commence within 2 years of transplantation. “Although the absolute risk of CRC in individuals with CF is extremely low for patients younger than 30 years, the risk … greatly increases after lung transplantation,” to 25-30 times the age-adjusted baseline, the panel wrote. “Increased posttransplantation survival means that many transplant patients will enter older age groups where there is an increased risk of cancer.” Screening should be performed after recovery and within 2 years, unless there was a negative colonoscopy in the 5 years before transplant.
  • Thereafter, patients who have had a solid organ transplant should undergo colonoscopy every 5 years, based on their life expectancy. “In cases where the expected survival time is limited (less than 10 years), screening should not be performed. For adults appropriately selected, lung transplantation usually increases survival probability. Therefore, a lung transplantation candidate with a short life expectancy is likely to become a screening candidate before and after transplantation at the appropriate ages described here, because the potential survival increases to approximately 10 years.”
  • Colonoscopy should be repeated every 3 years on CF patients with transplants with a history of adenomatous polyps. This interval may be as short as 1 year for patients with high-risk, large, or multiple polyps.
  • CF patients should undergo more intense bowel prep for colonoscopy, with three-four washes of a minimum of one liter of purgative per wash; the last wash should occur 4-6 hours before the procedure. Split-prep regimens (several smaller-volume washes) are better than a single larger-volume wash. The panel suggested a sample CF-specific regimen available from the Minnesota Cystic Fibrosis Center.
 

 

The new document reflects expert consensus on the currently available data, the panel said. As more data emerge, the recommendations might change.

“It is possible that different subpopulations will need more or less frequent schedules for rescreening and surveillance. Our recommendations are making an effort to balance the risk of missing advanced colorectal cancer and minimizing the burden and risk of too frequent examinations.”

None of the panel members had any financial disclosures.

SOURCE: Hadjiliadis D et al. Gastroenterology. 2017 Dec 28. doi. org/10.1053/j.gastro.2017.12.012

Publications
Publications
Topics
Article Type
Sections
Article Source

FROM GASTROENTEROLOGY

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default

VIDEO: Gluten-free diet tied to heavy metal bioaccumulation

Article Type
Changed

 

A gluten-free diet was associated with significantly increased blood levels of mercury, lead, and cadmium and with significantly increased urinary levels of arsenic in a large cross-sectional population-based survey study.

Source: American Gastroenterological Association

After researchers controlled for demographic characteristics, “levels of all heavy metals remained significantly higher in persons following a gluten-free diet, compared with those not following a gluten-free diet,” Stephanie L. Raehsler, MPH, of Mayo Clinic in Rochester, Minn., wrote with her associates in an article published in the February issue of Clinical Gastroenterology and Hepatology.

The purported (unproven) benefits of a gluten-free diet (GFD) have propelled them into the mainstream outside the settings of celiac disease, dermatitis herpetiformis, and wheat allergy. However, GFDs have been linked to nutritional deficits of iron, ferritin, zinc, and fiber, to increased consumption of sugar, fats, and salt, and to excessive bioaccumulation of mercury, the investigators noted.

High intake of rice, a staple of many GFDs, also has been associated with elevated urinary excretion of arsenic (PLoS One. 2014 Sep 8;9[9]:e104768. doi: 10.1371/journal.pone.0104768). To further characterize these relationships, the researchers analyzed data for 2009 through 2012 from 11,354 participants in the National Health and Nutrition Examination Survey (NHANES). Blood levels of lead, mercury, and cadmium were available from 115 participants who reported following a GFD, and data on urinary arsenic levels were available from 32 such individuals.

In the overall study group, blood mercury levels averaged 1.37 mcg/L (95% confidence interval, 1.02-1.85 mcg/L) among persons on a GFD and 0.93 mcg/L (95% CI, 0.86-1.0 mcg/L) in persons not on a GFD (P = .008). Individuals on a GFD also had significantly higher total blood levels of lead (1.42 vs. 1.13 mcg/L; P = .007 ) and cadmium (0.42 vs. 0.34; P = .03), and they had significantly higher urinary levels of total arsenic (15.2 vs. 8.4 mcg/L; P = .003). These significant differences persisted after researchers controlled for age, sex, race, and smoking status.

Additionally, among 101 individuals on GFDs who had no laboratory or clinical indication of celiac disease, blood levels of total mercury were significantly elevated, compared with individuals not on a GFD (1.40 vs. 0.93 mcg/L; P = .02), as were blood lead concentrations (1.44 vs. 1.13 mcg/L; P = .01) and urinary arsenic levels (14.7 vs. 8.3 mcg/L; P = .01). Blood cadmium levels also were increased (0.42 vs. 0.34 mcg/L), but this difference did not reach statistical significance (P = .06).

Individuals who reported eating fish or shellfish in the past month had higher blood mercury levels than those who did not, regardless of whether they were on a GFD. However, only two individuals in the study exceeded the toxicity threshold for mercury and neither was on a GFD, the researchers said. For most individuals on a GFD, levels of all heavy metals except urinary arsenic stayed under the recognized limits for toxicity, they noted.

The number of respondents following a GFD was small, but the investigators followed NHANES recommendations on sampling weights and sample design variables. Also, although the NHANES included only one question on GFDs, trained interviewers were used to help minimize bias. “Studies are needed to determine the long-term effects of accumulation of these elements in persons on a GFD,” the researchers concluded.

The Centers for Disease Control and Prevention provided partial funding. The researchers reported having no conflicts of interest.
 

SOURCE: Raehsler S et al. Clin Gastro Hepatol. 2018;(in press).

Publications
Topics
Sections

 

A gluten-free diet was associated with significantly increased blood levels of mercury, lead, and cadmium and with significantly increased urinary levels of arsenic in a large cross-sectional population-based survey study.

Source: American Gastroenterological Association

After researchers controlled for demographic characteristics, “levels of all heavy metals remained significantly higher in persons following a gluten-free diet, compared with those not following a gluten-free diet,” Stephanie L. Raehsler, MPH, of Mayo Clinic in Rochester, Minn., wrote with her associates in an article published in the February issue of Clinical Gastroenterology and Hepatology.

The purported (unproven) benefits of a gluten-free diet (GFD) have propelled them into the mainstream outside the settings of celiac disease, dermatitis herpetiformis, and wheat allergy. However, GFDs have been linked to nutritional deficits of iron, ferritin, zinc, and fiber, to increased consumption of sugar, fats, and salt, and to excessive bioaccumulation of mercury, the investigators noted.

High intake of rice, a staple of many GFDs, also has been associated with elevated urinary excretion of arsenic (PLoS One. 2014 Sep 8;9[9]:e104768. doi: 10.1371/journal.pone.0104768). To further characterize these relationships, the researchers analyzed data for 2009 through 2012 from 11,354 participants in the National Health and Nutrition Examination Survey (NHANES). Blood levels of lead, mercury, and cadmium were available from 115 participants who reported following a GFD, and data on urinary arsenic levels were available from 32 such individuals.

In the overall study group, blood mercury levels averaged 1.37 mcg/L (95% confidence interval, 1.02-1.85 mcg/L) among persons on a GFD and 0.93 mcg/L (95% CI, 0.86-1.0 mcg/L) in persons not on a GFD (P = .008). Individuals on a GFD also had significantly higher total blood levels of lead (1.42 vs. 1.13 mcg/L; P = .007 ) and cadmium (0.42 vs. 0.34; P = .03), and they had significantly higher urinary levels of total arsenic (15.2 vs. 8.4 mcg/L; P = .003). These significant differences persisted after researchers controlled for age, sex, race, and smoking status.

Additionally, among 101 individuals on GFDs who had no laboratory or clinical indication of celiac disease, blood levels of total mercury were significantly elevated, compared with individuals not on a GFD (1.40 vs. 0.93 mcg/L; P = .02), as were blood lead concentrations (1.44 vs. 1.13 mcg/L; P = .01) and urinary arsenic levels (14.7 vs. 8.3 mcg/L; P = .01). Blood cadmium levels also were increased (0.42 vs. 0.34 mcg/L), but this difference did not reach statistical significance (P = .06).

Individuals who reported eating fish or shellfish in the past month had higher blood mercury levels than those who did not, regardless of whether they were on a GFD. However, only two individuals in the study exceeded the toxicity threshold for mercury and neither was on a GFD, the researchers said. For most individuals on a GFD, levels of all heavy metals except urinary arsenic stayed under the recognized limits for toxicity, they noted.

The number of respondents following a GFD was small, but the investigators followed NHANES recommendations on sampling weights and sample design variables. Also, although the NHANES included only one question on GFDs, trained interviewers were used to help minimize bias. “Studies are needed to determine the long-term effects of accumulation of these elements in persons on a GFD,” the researchers concluded.

The Centers for Disease Control and Prevention provided partial funding. The researchers reported having no conflicts of interest.
 

SOURCE: Raehsler S et al. Clin Gastro Hepatol. 2018;(in press).

 

A gluten-free diet was associated with significantly increased blood levels of mercury, lead, and cadmium and with significantly increased urinary levels of arsenic in a large cross-sectional population-based survey study.

Source: American Gastroenterological Association

After researchers controlled for demographic characteristics, “levels of all heavy metals remained significantly higher in persons following a gluten-free diet, compared with those not following a gluten-free diet,” Stephanie L. Raehsler, MPH, of Mayo Clinic in Rochester, Minn., wrote with her associates in an article published in the February issue of Clinical Gastroenterology and Hepatology.

The purported (unproven) benefits of a gluten-free diet (GFD) have propelled them into the mainstream outside the settings of celiac disease, dermatitis herpetiformis, and wheat allergy. However, GFDs have been linked to nutritional deficits of iron, ferritin, zinc, and fiber, to increased consumption of sugar, fats, and salt, and to excessive bioaccumulation of mercury, the investigators noted.

High intake of rice, a staple of many GFDs, also has been associated with elevated urinary excretion of arsenic (PLoS One. 2014 Sep 8;9[9]:e104768. doi: 10.1371/journal.pone.0104768). To further characterize these relationships, the researchers analyzed data for 2009 through 2012 from 11,354 participants in the National Health and Nutrition Examination Survey (NHANES). Blood levels of lead, mercury, and cadmium were available from 115 participants who reported following a GFD, and data on urinary arsenic levels were available from 32 such individuals.

In the overall study group, blood mercury levels averaged 1.37 mcg/L (95% confidence interval, 1.02-1.85 mcg/L) among persons on a GFD and 0.93 mcg/L (95% CI, 0.86-1.0 mcg/L) in persons not on a GFD (P = .008). Individuals on a GFD also had significantly higher total blood levels of lead (1.42 vs. 1.13 mcg/L; P = .007 ) and cadmium (0.42 vs. 0.34; P = .03), and they had significantly higher urinary levels of total arsenic (15.2 vs. 8.4 mcg/L; P = .003). These significant differences persisted after researchers controlled for age, sex, race, and smoking status.

Additionally, among 101 individuals on GFDs who had no laboratory or clinical indication of celiac disease, blood levels of total mercury were significantly elevated, compared with individuals not on a GFD (1.40 vs. 0.93 mcg/L; P = .02), as were blood lead concentrations (1.44 vs. 1.13 mcg/L; P = .01) and urinary arsenic levels (14.7 vs. 8.3 mcg/L; P = .01). Blood cadmium levels also were increased (0.42 vs. 0.34 mcg/L), but this difference did not reach statistical significance (P = .06).

Individuals who reported eating fish or shellfish in the past month had higher blood mercury levels than those who did not, regardless of whether they were on a GFD. However, only two individuals in the study exceeded the toxicity threshold for mercury and neither was on a GFD, the researchers said. For most individuals on a GFD, levels of all heavy metals except urinary arsenic stayed under the recognized limits for toxicity, they noted.

The number of respondents following a GFD was small, but the investigators followed NHANES recommendations on sampling weights and sample design variables. Also, although the NHANES included only one question on GFDs, trained interviewers were used to help minimize bias. “Studies are needed to determine the long-term effects of accumulation of these elements in persons on a GFD,” the researchers concluded.

The Centers for Disease Control and Prevention provided partial funding. The researchers reported having no conflicts of interest.
 

SOURCE: Raehsler S et al. Clin Gastro Hepatol. 2018;(in press).

Publications
Publications
Topics
Article Type
Sections
Article Source

FROM CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Vitals

 

Key clinical point: A gluten-free diet was associated with significantly increased bioaccumulation of several heavy metals.

Major finding: After accounting for demographic factors, blood or urinary levels of lead, cadmium, arsenic, and mercury were significantly higher in persons following a gluten-free diet, compared with those who did not follow a gluten-free diet.

Data source: A population-based, cross-sectional study of 11,354 respondents to NHANES 2009-2012, including 115 persons on a gluten-free diet.

Disclosures: The Centers for Disease Control and Prevention provided partial funding. The researchers reported having no conflicts of interest.

Source: Raehsler S et al. Clin Gastro Hepatol. 2018 (in press).

Disqus Comments
Default

Using Intraindividual Variability to Evaluate Pediatric Epilepsy

Article Type
Changed
Epilepsy Behav; 2018 Feb; Srnka et al.

The ability of a patient to focus over time is often impaired among children with epilepsy, and intraindividual variability may be an important way to measure such attentional problems according to a study published in Epilepsy & Behavior.

  • Intraindividual variability, a measure of changes in an individual’s transient behavioral performance, has been identified in both pediatric and adult patients with epilepsy.
  • Srnka et al evaluated intraindividual variability in 144 patients who had just been diagnosed with epilepsy, using the Connors Continuous Performance Task-II as a metric.
  • The children with epilepsy were between the ages of 8 and 18 years and were compared to 82 healthy children.
  • The researchers found a large difference in variability between the two groups, with an effect size difference of 0.68.
  • They also discovered that intraindividual variability predicted intellectual functioning and academic achievement.

Srnka K, Seidenberg M, Hermann B, Jones J. Intraindividual variability in attentional vigilance in children with epilepsy.  Epilepsy Behav. 2018;79:42-45.

Publications
Sections
Epilepsy Behav; 2018 Feb; Srnka et al.
Epilepsy Behav; 2018 Feb; Srnka et al.

The ability of a patient to focus over time is often impaired among children with epilepsy, and intraindividual variability may be an important way to measure such attentional problems according to a study published in Epilepsy & Behavior.

  • Intraindividual variability, a measure of changes in an individual’s transient behavioral performance, has been identified in both pediatric and adult patients with epilepsy.
  • Srnka et al evaluated intraindividual variability in 144 patients who had just been diagnosed with epilepsy, using the Connors Continuous Performance Task-II as a metric.
  • The children with epilepsy were between the ages of 8 and 18 years and were compared to 82 healthy children.
  • The researchers found a large difference in variability between the two groups, with an effect size difference of 0.68.
  • They also discovered that intraindividual variability predicted intellectual functioning and academic achievement.

Srnka K, Seidenberg M, Hermann B, Jones J. Intraindividual variability in attentional vigilance in children with epilepsy.  Epilepsy Behav. 2018;79:42-45.

The ability of a patient to focus over time is often impaired among children with epilepsy, and intraindividual variability may be an important way to measure such attentional problems according to a study published in Epilepsy & Behavior.

  • Intraindividual variability, a measure of changes in an individual’s transient behavioral performance, has been identified in both pediatric and adult patients with epilepsy.
  • Srnka et al evaluated intraindividual variability in 144 patients who had just been diagnosed with epilepsy, using the Connors Continuous Performance Task-II as a metric.
  • The children with epilepsy were between the ages of 8 and 18 years and were compared to 82 healthy children.
  • The researchers found a large difference in variability between the two groups, with an effect size difference of 0.68.
  • They also discovered that intraindividual variability predicted intellectual functioning and academic achievement.

Srnka K, Seidenberg M, Hermann B, Jones J. Intraindividual variability in attentional vigilance in children with epilepsy.  Epilepsy Behav. 2018;79:42-45.

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default

Finding a Presurgical Role for Magnetoencephalography

Article Type
Changed
Epilepsy Behav; 2018 Feb; Mohamed et al.

Magnetoencephalography (MEG) may play an important role in the presurgical workup of patients with nonlesional refractory focal epilepsy suggests a recent observational study.

  • Investigators observed 31 patients at an academic epilepsy center to determine if MEG would have had an impact on patient care; (they were unable to analyze the MEG early enough to influence the decision-making process).
  • Had the test been integrated into the presurgical workup, 68% of patients would have received different management initially.
  • MEG would have reduced the number of patients who received intracranial electrodes.
  • MEG would also have led to the position of the electrodes being changed or provided adequate evidence to justify the use of an intracranial electrode.
  • The results of the MEG studies would have let surgeons do direct surgery with no need for intracranial electrodes in 2 of 11 patients.
  • 6 patients fared poorly after surgery, but MEG would have changed their outcomes in 3 of these patients by modifying the resection margin.

Mohamed IS, Bout hillier A, Bérubé A, et al. The clinical impact of integration of magnetoencephalography in the presurgical workup for refractory nonlesional epilepsy. Epilepsy Behav. 2018;79:34-41.

Publications
Sections
Epilepsy Behav; 2018 Feb; Mohamed et al.
Epilepsy Behav; 2018 Feb; Mohamed et al.

Magnetoencephalography (MEG) may play an important role in the presurgical workup of patients with nonlesional refractory focal epilepsy suggests a recent observational study.

  • Investigators observed 31 patients at an academic epilepsy center to determine if MEG would have had an impact on patient care; (they were unable to analyze the MEG early enough to influence the decision-making process).
  • Had the test been integrated into the presurgical workup, 68% of patients would have received different management initially.
  • MEG would have reduced the number of patients who received intracranial electrodes.
  • MEG would also have led to the position of the electrodes being changed or provided adequate evidence to justify the use of an intracranial electrode.
  • The results of the MEG studies would have let surgeons do direct surgery with no need for intracranial electrodes in 2 of 11 patients.
  • 6 patients fared poorly after surgery, but MEG would have changed their outcomes in 3 of these patients by modifying the resection margin.

Mohamed IS, Bout hillier A, Bérubé A, et al. The clinical impact of integration of magnetoencephalography in the presurgical workup for refractory nonlesional epilepsy. Epilepsy Behav. 2018;79:34-41.

Magnetoencephalography (MEG) may play an important role in the presurgical workup of patients with nonlesional refractory focal epilepsy suggests a recent observational study.

  • Investigators observed 31 patients at an academic epilepsy center to determine if MEG would have had an impact on patient care; (they were unable to analyze the MEG early enough to influence the decision-making process).
  • Had the test been integrated into the presurgical workup, 68% of patients would have received different management initially.
  • MEG would have reduced the number of patients who received intracranial electrodes.
  • MEG would also have led to the position of the electrodes being changed or provided adequate evidence to justify the use of an intracranial electrode.
  • The results of the MEG studies would have let surgeons do direct surgery with no need for intracranial electrodes in 2 of 11 patients.
  • 6 patients fared poorly after surgery, but MEG would have changed their outcomes in 3 of these patients by modifying the resection margin.

Mohamed IS, Bout hillier A, Bérubé A, et al. The clinical impact of integration of magnetoencephalography in the presurgical workup for refractory nonlesional epilepsy. Epilepsy Behav. 2018;79:34-41.

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default

Comparing PreOp High-Gamma Modulation With Electrical Stimulation

Article Type
Changed
Epilepsy Behav; 2018 Feb; Arya et al.

Electrocorticographic (ECoG) high-γ modulation (HGM) can serve as a specific way to localize language preoperatively, when compared with electrical stimulation mapping (ESM), which is considered the gold standard, according to a recent meta-analysis. But the same analysis concluded that it was not sensitive enough when compared with ESM.

  • The meta-analysis reviewed several metrics for diagnostic validity, including area under the summary receiver operating characteristic (SROC) curve, diagnostic odds ratio, and pooled estimates of sensitivity and specificity.
  • To determine language mapping, the most common task used was overt picture naming.
  • ECoG was analyzed at 50 to 400 Hz, with different studies using different bandwidths.
  • Among the studies that looked at ESM, there were wide variations in pulse duration, train duration, and maximum current.
  • The pooled diagnostic odds ratio was 6.44 and the AUC was 0.77, making HGM a fairly reliable way to ascertain electrodes overlying ESM cortical language sites.

Aryaa R, Horn PS, Crone NE, et al. ECoG high-gamma modulation versus electrical stimulation for presurgical language mapping. Epilepsy Behav. 2018;79:26-33.

Publications
Sections
Epilepsy Behav; 2018 Feb; Arya et al.
Epilepsy Behav; 2018 Feb; Arya et al.

Electrocorticographic (ECoG) high-γ modulation (HGM) can serve as a specific way to localize language preoperatively, when compared with electrical stimulation mapping (ESM), which is considered the gold standard, according to a recent meta-analysis. But the same analysis concluded that it was not sensitive enough when compared with ESM.

  • The meta-analysis reviewed several metrics for diagnostic validity, including area under the summary receiver operating characteristic (SROC) curve, diagnostic odds ratio, and pooled estimates of sensitivity and specificity.
  • To determine language mapping, the most common task used was overt picture naming.
  • ECoG was analyzed at 50 to 400 Hz, with different studies using different bandwidths.
  • Among the studies that looked at ESM, there were wide variations in pulse duration, train duration, and maximum current.
  • The pooled diagnostic odds ratio was 6.44 and the AUC was 0.77, making HGM a fairly reliable way to ascertain electrodes overlying ESM cortical language sites.

Aryaa R, Horn PS, Crone NE, et al. ECoG high-gamma modulation versus electrical stimulation for presurgical language mapping. Epilepsy Behav. 2018;79:26-33.

Electrocorticographic (ECoG) high-γ modulation (HGM) can serve as a specific way to localize language preoperatively, when compared with electrical stimulation mapping (ESM), which is considered the gold standard, according to a recent meta-analysis. But the same analysis concluded that it was not sensitive enough when compared with ESM.

  • The meta-analysis reviewed several metrics for diagnostic validity, including area under the summary receiver operating characteristic (SROC) curve, diagnostic odds ratio, and pooled estimates of sensitivity and specificity.
  • To determine language mapping, the most common task used was overt picture naming.
  • ECoG was analyzed at 50 to 400 Hz, with different studies using different bandwidths.
  • Among the studies that looked at ESM, there were wide variations in pulse duration, train duration, and maximum current.
  • The pooled diagnostic odds ratio was 6.44 and the AUC was 0.77, making HGM a fairly reliable way to ascertain electrodes overlying ESM cortical language sites.

Aryaa R, Horn PS, Crone NE, et al. ECoG high-gamma modulation versus electrical stimulation for presurgical language mapping. Epilepsy Behav. 2018;79:26-33.

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default

Conference News Roundup—Society for Neuroscience

Article Type
Changed

Transcranial Magnetic Stimulation Improves Memory in Older Adults

A painless and noninvasive brain stimulation technique may help improve some types of memory in older adults, investigators reported.

One possible explanation for age-related memory loss is degradation of the neural connections between the hippocampus and the cortex. Weakening of these connections may lead to difficulties in creating new memories of specific events and the locations of objects. Scientists hypothesized that strengthening the connections between the hippocampus and cortex through repetitive transcranial magnetic stimulation (TMS) may help the storage of new memories. TMS delivers painless magnetic pulses to a particular region of the brain, changing the activity of the neurons within the targeted area.

To determine whether TMS could improve memory, 15 healthy adults over the age of 64 received TMS to a part of the cortex that communicates with the hippocampus. Treatment lasted for five days. During a separate week, each participant received five days of sham treatment, in which the setup was the same, but the stimulation was too low to influence the neural connections. Before and after each five-day session, participants were asked to remember pictures of everyday objects and pictures of outdoor scenes associated with each one. The adults’ ability to recall the scenes associated with the objects improved after receiving TMS, but not after the sham treatment.

“Our study demonstrates that TMS could potentially be used as a way to improve memory for older adults experiencing age-related memory impairments,” said John A. Walker, PhD, postdoctorate fellow at Northwestern University in Evanston, Illinois. “TMS can be used to probe the relationship between brain networks and memory experimentally, opening new doors to understanding the network basis of cognitive decline in aging.”

Heading the Ball Hurts Women More Than Men

Intentionally hitting a soccer ball with the head, or “heading,” may have more adverse brain consequences for women than men, said researchers.

Heading does not typically result in a concussion, yet growing evidence links the move to CNS damage. Previous studies using diffusion tensor imaging (DTI) have revealed that heading damages the integrity of the axons. Women appear to be more vulnerable than men to problems associated with heading, as they report more symptoms that last longer, but the reason for these gender differences remains unknown.

To assess possible gender differences in the effects of heading, researchers used DTI to examine 49 male and 49 female amateur soccer players who were matched on age and frequency of heading. Higher levels of heading were associated with decreased axonal integrity in three brain regions for men and eight brain regions for women. In seven of the areas identified in women, the association between axonal integrity and heading was significantly stronger than it was in men.

“Given similar amounts of exposure to heading, women show a greater volume of abnormality that is significantly different from what is seen in men,” said lead author Todd G. Rubin, MD, a doctoral student at Albert Einstein College of Medicine in Bronx, New York. “Identifying and understanding the basis for differences in susceptibility to injury represent key steps in determining better treatments and guidelines for safer play.”

DBS Can Individualize Treatment for Parkinson’s Disease

A new approach to deep brain stimulation (DBS) adjusts itself to deliver the appropriate amount of stimulation in patients with Parkinson’s disease, according to new research. The approach could improve symptom management and reduce side effects.

DBS has been a valuable treatment for Parkinson’s disease by helping to quell the abnormal movements that are characteristic of the disease. Traditional DBS delivers a constant level of stimulation and cannot adapt if a patient’s symptoms vary over the course of a day. As a result, a patient may sometimes receive too little stimulation, which fails to control symptoms, or too much, which causes side effects such as dyskinesia.

To match stimulation to variations in patient symptoms throughout the day, researchers and engineers developed a novel implantable device that provides DBS and records activity from the surface of the brain. Similar to a cardiac pacemaker, this adaptive device can autoadjust its level of stimulation based on a physiologic signal—in this case, brain activity related to dyskinesia. A high dyskinesia signal indicated greater likelihood of unwanted side effects and caused the device to reduce the stimulation level. A low signal indicated a higher chance of symptoms returning and triggered an increase in stimulation.

The device was tested in two patients inside and outside of the laboratory. Neither patient reported discomfort, adverse events, or worsening symptoms. In addition, the battery used as much as 45% less energy than traditional DBS, which is an important advantage, since battery replacement requires surgery.

“Our study showed that totally implanted, adaptive DBS is feasible and can be used at home in patients,” said lead author Nicole C. Swann, PhD, Assistant Professor of Human Physiology at the University of Oregon in Eugene. “Adaptive stimulation represents one of the first major advances in DBS technology since this technique was first introduced for the treatment of Parkinson’s disease 25 years ago.”

 

 

Contact Sports May Impair Memory Temporarily

Sports-related head injuries may prevent the generation of new neurons in a brain region important for memory, said investigators.

Concussion can lead to cognitive impairments, and recent evidence indicates that subconcussive hits can cause damage. The hippocampus is particularly vulnerable. One way to test the effects of head impacts on the hippocampus is a memory assessment called the mnemonic similarity test (MST), which evaluates a person’s ability to distinguish between images that are novel, previously presented, or similar to images previously presented. Accumulating evidence suggests that MST scores are related to the hippocampus’s ability to generate new neurons.

To investigate changes in memory following sports-related head injuries, researchers assessed different types of athletes in two studies. In the first study, they compared athletes with concussion, uninjured athletes who played the same sport, same-sport athletes with musculoskeletal injuries, and healthy controls. Compared with the other three groups, concussed athletes performed worse on the MST when tested two to four weeks after their injury. The scores did not remain low, however. By the time the athletes were cleared to play, their scores had improved to normal levels.

In the second study, rugby players were given the MST before the season started, halfway through the season, and one month after their last game. Scores dropped midseason, compared with preseason scores, but recovered by the postseason assessment.

“Using a cognitive test believed to be sensitive to hippocampal neurogenesis, we found that athletes with concussion show impairments that resolve following recovery,” said lead author Melissa Danielle McCradden, PhD, a postdoctoral fellow at McMaster University in Toronto. “These findings represent, to the best of our knowledge, the first reported evidence in humans suggesting a brain change that might explain the cognitive and emotional symptoms associated with mild traumatic brain injury.”

Disrupted Brain Networks May Cause Gulf War Illness

The brains of veterans with Gulf War illness (GWI) show widespread communication abnormalities in networks that support various brain functions, researchers reported. The observed patterns of impairment provide objective neurophysiologic evidence to support the self-reported symptoms of veterans with GWI.

As many as 250,000 veterans who served in Iraq, Kuwait, and Saudi Arabia during the 1991 Gulf War may currently experience GWI. Symptoms include difficulty remembering things, trouble finding words while speaking, motor coordination, mood swings, fatigue, and chronic pain. GWI is thought to result from exposure to a mix of chemical and biological warfare agents and hazardous chemicals.

To better understand brain changes in GWI, researchers compared the brains of 22 veterans with GWI to the brains of 30 healthy veterans of similar age. Using resting state functional MRI, researchers analyzed patterns of communication among regions of the brain known to control different functions and behavior. They identified changes in functional networks related to many commonly reported GWI symptoms. Individuals with GWI showed clear deficits in neural communication in the sectors of the brain responsible for visual processing, mood regulation, motor coordination, sensory processing, and language command, but increased communication in networks related to pain perception during rest.

“The results from this study provide strong evidence of neuropathology in GWI patients from exposures to neurotoxic agents,” said lead author Kaundinya Gopinath, PhD, Assistant Professor of Radiology and Imaging Sciences at Emory University in Atlanta. Next, “the aim is to establish brain mechanisms underlying GWI, which in turn can lead to development of treatments.”

Prolonged Sedation May Cause Brain Abnormalities in Infants

Full-term infants who undergo repeated anesthesia and prolonged sedation are at risk for changes in brain development, according to investigators.

Developmental impacts of prenatal exposure to sedatives have been studied widely, but less is known about the immediate and long-term neurologic and developmental effects of prolonged sedation when administered to critically ill infants after birth. Prolonged administration of opioids and benzodiazepines, which commonly are used for infants undergoing surgery, is associated with a high incidence of drug tolerance and dependence. Although negative long-term outcomes have been associated with such drug exposures in infants, these studies could not exclude other possible causes, such as prematurity or heart problems.

To study neurologic effects of prolonged sedation, researchers conducted MRI scans on full-term infants who underwent life-saving surgery that required prolonged exposure to morphine and midazolam before one year of age. Brain imaging showed several brain MRI anomalies that were not present in healthy infants, including abnormalities in gray and white matter structures and the ventricles. The number of brain MRI abnormalities significantly correlated with the average daily dose of these sedative drugs. The higher the daily dose, the more MRI irregularities were seen. The patients also had more brain fluid and a smaller total brain volume, compared with healthy infants. This pattern has been associated with long-term neurodevelopmental outcomes such as autism spectrum disorder. Taken together, these preliminary findings indicate a potential negative impact of prolonged sedation on brain growth during the first year of life, the researchers said.

“We were surprised to find higher incidence of brain abnormalities in full-term infants who underwent life-saving surgery that required prolonged sedation,” said senior author Dusica Bajic, MD, PhD, Principal Investigator at Boston Children’s Hospital. “The constellation of MRI irregularities suggests prolonged sedation may potentially contribute to delayed brain growth.” Future investigations will explore the neural mechanisms of the observed developmental effects and whether early sedation exposure may lead to long-term neurobehavioral impacts.

 

 

The Brain Preferentially Reactivates Negative Memories During Sleep

The brain selectively reactivates negative memories during sleep, prioritizing the retention of these emotional memories, which may be of greater future relevance than neutral memories and thus more worth remembering, according to investigators.

Over the past two decades, neuroscientists have gained increased understanding of how sleep boosts and stabilizes memories in the human brain. In the current study, researchers presented 57 healthy volunteers with a series of neutral and negative images. While staring straight ahead, the volunteers saw all of the negative images on one side of their field of vision (left) and all of the neutral images on the other side (right). Because the brain processes visual information in the opposite hemisphere from where it is viewed, this method allowed researchers to “tag” one hemisphere with negative content and the other with neutral content, thus enabling them to track localized memories. Participants were then shown the previously seen images for memory tests, with some of the images shown immediately after the learning phase and the rest shown after a period of wakefulness or sleep. During all memory tests, volunteers viewed the images directly in front of them, rather than to either side, and researchers asked participants to state whether an image had originally appeared to the left or right.

Participants who stayed awake in between memory tests forgot some of the original image locations, but forgetting was similar for neutral and negative images. Participants who slept between tests, on the other hand, had a much better rate of recall for the negative images than for the neutral ones. EEG recordings made during the learning phase show that the brain has encoded the distinct types of memories in its two hemispheres, with the negative images strongly encoded in the hemisphere opposite to the side of presentation. Researchers are now analyzing data that they hypothesize will show that the waking EEG pattern corresponding to emotional memories is the same pattern that is reactivated most strongly during sleep.

“This [finding] would provide a long sought-after brain-based explanation of how sleep selectively stabilizes emotional memories,” said lead author Roy Cox, PhD, research fellow in psychiatry at Beth Israel Deaconess Medical Center in Boston. “Our research substantially advances the notion that sleep plays a fundamental and complex role in the offline reorganization of waking experiences.”

Issue
Neurology Reviews - 26(2)
Publications
Topics
Page Number
64-65
Sections

Transcranial Magnetic Stimulation Improves Memory in Older Adults

A painless and noninvasive brain stimulation technique may help improve some types of memory in older adults, investigators reported.

One possible explanation for age-related memory loss is degradation of the neural connections between the hippocampus and the cortex. Weakening of these connections may lead to difficulties in creating new memories of specific events and the locations of objects. Scientists hypothesized that strengthening the connections between the hippocampus and cortex through repetitive transcranial magnetic stimulation (TMS) may help the storage of new memories. TMS delivers painless magnetic pulses to a particular region of the brain, changing the activity of the neurons within the targeted area.

To determine whether TMS could improve memory, 15 healthy adults over the age of 64 received TMS to a part of the cortex that communicates with the hippocampus. Treatment lasted for five days. During a separate week, each participant received five days of sham treatment, in which the setup was the same, but the stimulation was too low to influence the neural connections. Before and after each five-day session, participants were asked to remember pictures of everyday objects and pictures of outdoor scenes associated with each one. The adults’ ability to recall the scenes associated with the objects improved after receiving TMS, but not after the sham treatment.

“Our study demonstrates that TMS could potentially be used as a way to improve memory for older adults experiencing age-related memory impairments,” said John A. Walker, PhD, postdoctorate fellow at Northwestern University in Evanston, Illinois. “TMS can be used to probe the relationship between brain networks and memory experimentally, opening new doors to understanding the network basis of cognitive decline in aging.”

Heading the Ball Hurts Women More Than Men

Intentionally hitting a soccer ball with the head, or “heading,” may have more adverse brain consequences for women than men, said researchers.

Heading does not typically result in a concussion, yet growing evidence links the move to CNS damage. Previous studies using diffusion tensor imaging (DTI) have revealed that heading damages the integrity of the axons. Women appear to be more vulnerable than men to problems associated with heading, as they report more symptoms that last longer, but the reason for these gender differences remains unknown.

To assess possible gender differences in the effects of heading, researchers used DTI to examine 49 male and 49 female amateur soccer players who were matched on age and frequency of heading. Higher levels of heading were associated with decreased axonal integrity in three brain regions for men and eight brain regions for women. In seven of the areas identified in women, the association between axonal integrity and heading was significantly stronger than it was in men.

“Given similar amounts of exposure to heading, women show a greater volume of abnormality that is significantly different from what is seen in men,” said lead author Todd G. Rubin, MD, a doctoral student at Albert Einstein College of Medicine in Bronx, New York. “Identifying and understanding the basis for differences in susceptibility to injury represent key steps in determining better treatments and guidelines for safer play.”

DBS Can Individualize Treatment for Parkinson’s Disease

A new approach to deep brain stimulation (DBS) adjusts itself to deliver the appropriate amount of stimulation in patients with Parkinson’s disease, according to new research. The approach could improve symptom management and reduce side effects.

DBS has been a valuable treatment for Parkinson’s disease by helping to quell the abnormal movements that are characteristic of the disease. Traditional DBS delivers a constant level of stimulation and cannot adapt if a patient’s symptoms vary over the course of a day. As a result, a patient may sometimes receive too little stimulation, which fails to control symptoms, or too much, which causes side effects such as dyskinesia.

To match stimulation to variations in patient symptoms throughout the day, researchers and engineers developed a novel implantable device that provides DBS and records activity from the surface of the brain. Similar to a cardiac pacemaker, this adaptive device can autoadjust its level of stimulation based on a physiologic signal—in this case, brain activity related to dyskinesia. A high dyskinesia signal indicated greater likelihood of unwanted side effects and caused the device to reduce the stimulation level. A low signal indicated a higher chance of symptoms returning and triggered an increase in stimulation.

The device was tested in two patients inside and outside of the laboratory. Neither patient reported discomfort, adverse events, or worsening symptoms. In addition, the battery used as much as 45% less energy than traditional DBS, which is an important advantage, since battery replacement requires surgery.

“Our study showed that totally implanted, adaptive DBS is feasible and can be used at home in patients,” said lead author Nicole C. Swann, PhD, Assistant Professor of Human Physiology at the University of Oregon in Eugene. “Adaptive stimulation represents one of the first major advances in DBS technology since this technique was first introduced for the treatment of Parkinson’s disease 25 years ago.”

 

 

Contact Sports May Impair Memory Temporarily

Sports-related head injuries may prevent the generation of new neurons in a brain region important for memory, said investigators.

Concussion can lead to cognitive impairments, and recent evidence indicates that subconcussive hits can cause damage. The hippocampus is particularly vulnerable. One way to test the effects of head impacts on the hippocampus is a memory assessment called the mnemonic similarity test (MST), which evaluates a person’s ability to distinguish between images that are novel, previously presented, or similar to images previously presented. Accumulating evidence suggests that MST scores are related to the hippocampus’s ability to generate new neurons.

To investigate changes in memory following sports-related head injuries, researchers assessed different types of athletes in two studies. In the first study, they compared athletes with concussion, uninjured athletes who played the same sport, same-sport athletes with musculoskeletal injuries, and healthy controls. Compared with the other three groups, concussed athletes performed worse on the MST when tested two to four weeks after their injury. The scores did not remain low, however. By the time the athletes were cleared to play, their scores had improved to normal levels.

In the second study, rugby players were given the MST before the season started, halfway through the season, and one month after their last game. Scores dropped midseason, compared with preseason scores, but recovered by the postseason assessment.

“Using a cognitive test believed to be sensitive to hippocampal neurogenesis, we found that athletes with concussion show impairments that resolve following recovery,” said lead author Melissa Danielle McCradden, PhD, a postdoctoral fellow at McMaster University in Toronto. “These findings represent, to the best of our knowledge, the first reported evidence in humans suggesting a brain change that might explain the cognitive and emotional symptoms associated with mild traumatic brain injury.”

Disrupted Brain Networks May Cause Gulf War Illness

The brains of veterans with Gulf War illness (GWI) show widespread communication abnormalities in networks that support various brain functions, researchers reported. The observed patterns of impairment provide objective neurophysiologic evidence to support the self-reported symptoms of veterans with GWI.

As many as 250,000 veterans who served in Iraq, Kuwait, and Saudi Arabia during the 1991 Gulf War may currently experience GWI. Symptoms include difficulty remembering things, trouble finding words while speaking, motor coordination, mood swings, fatigue, and chronic pain. GWI is thought to result from exposure to a mix of chemical and biological warfare agents and hazardous chemicals.

To better understand brain changes in GWI, researchers compared the brains of 22 veterans with GWI to the brains of 30 healthy veterans of similar age. Using resting state functional MRI, researchers analyzed patterns of communication among regions of the brain known to control different functions and behavior. They identified changes in functional networks related to many commonly reported GWI symptoms. Individuals with GWI showed clear deficits in neural communication in the sectors of the brain responsible for visual processing, mood regulation, motor coordination, sensory processing, and language command, but increased communication in networks related to pain perception during rest.

“The results from this study provide strong evidence of neuropathology in GWI patients from exposures to neurotoxic agents,” said lead author Kaundinya Gopinath, PhD, Assistant Professor of Radiology and Imaging Sciences at Emory University in Atlanta. Next, “the aim is to establish brain mechanisms underlying GWI, which in turn can lead to development of treatments.”

Prolonged Sedation May Cause Brain Abnormalities in Infants

Full-term infants who undergo repeated anesthesia and prolonged sedation are at risk for changes in brain development, according to investigators.

Developmental impacts of prenatal exposure to sedatives have been studied widely, but less is known about the immediate and long-term neurologic and developmental effects of prolonged sedation when administered to critically ill infants after birth. Prolonged administration of opioids and benzodiazepines, which commonly are used for infants undergoing surgery, is associated with a high incidence of drug tolerance and dependence. Although negative long-term outcomes have been associated with such drug exposures in infants, these studies could not exclude other possible causes, such as prematurity or heart problems.

To study neurologic effects of prolonged sedation, researchers conducted MRI scans on full-term infants who underwent life-saving surgery that required prolonged exposure to morphine and midazolam before one year of age. Brain imaging showed several brain MRI anomalies that were not present in healthy infants, including abnormalities in gray and white matter structures and the ventricles. The number of brain MRI abnormalities significantly correlated with the average daily dose of these sedative drugs. The higher the daily dose, the more MRI irregularities were seen. The patients also had more brain fluid and a smaller total brain volume, compared with healthy infants. This pattern has been associated with long-term neurodevelopmental outcomes such as autism spectrum disorder. Taken together, these preliminary findings indicate a potential negative impact of prolonged sedation on brain growth during the first year of life, the researchers said.

“We were surprised to find higher incidence of brain abnormalities in full-term infants who underwent life-saving surgery that required prolonged sedation,” said senior author Dusica Bajic, MD, PhD, Principal Investigator at Boston Children’s Hospital. “The constellation of MRI irregularities suggests prolonged sedation may potentially contribute to delayed brain growth.” Future investigations will explore the neural mechanisms of the observed developmental effects and whether early sedation exposure may lead to long-term neurobehavioral impacts.

 

 

The Brain Preferentially Reactivates Negative Memories During Sleep

The brain selectively reactivates negative memories during sleep, prioritizing the retention of these emotional memories, which may be of greater future relevance than neutral memories and thus more worth remembering, according to investigators.

Over the past two decades, neuroscientists have gained increased understanding of how sleep boosts and stabilizes memories in the human brain. In the current study, researchers presented 57 healthy volunteers with a series of neutral and negative images. While staring straight ahead, the volunteers saw all of the negative images on one side of their field of vision (left) and all of the neutral images on the other side (right). Because the brain processes visual information in the opposite hemisphere from where it is viewed, this method allowed researchers to “tag” one hemisphere with negative content and the other with neutral content, thus enabling them to track localized memories. Participants were then shown the previously seen images for memory tests, with some of the images shown immediately after the learning phase and the rest shown after a period of wakefulness or sleep. During all memory tests, volunteers viewed the images directly in front of them, rather than to either side, and researchers asked participants to state whether an image had originally appeared to the left or right.

Participants who stayed awake in between memory tests forgot some of the original image locations, but forgetting was similar for neutral and negative images. Participants who slept between tests, on the other hand, had a much better rate of recall for the negative images than for the neutral ones. EEG recordings made during the learning phase show that the brain has encoded the distinct types of memories in its two hemispheres, with the negative images strongly encoded in the hemisphere opposite to the side of presentation. Researchers are now analyzing data that they hypothesize will show that the waking EEG pattern corresponding to emotional memories is the same pattern that is reactivated most strongly during sleep.

“This [finding] would provide a long sought-after brain-based explanation of how sleep selectively stabilizes emotional memories,” said lead author Roy Cox, PhD, research fellow in psychiatry at Beth Israel Deaconess Medical Center in Boston. “Our research substantially advances the notion that sleep plays a fundamental and complex role in the offline reorganization of waking experiences.”

Transcranial Magnetic Stimulation Improves Memory in Older Adults

A painless and noninvasive brain stimulation technique may help improve some types of memory in older adults, investigators reported.

One possible explanation for age-related memory loss is degradation of the neural connections between the hippocampus and the cortex. Weakening of these connections may lead to difficulties in creating new memories of specific events and the locations of objects. Scientists hypothesized that strengthening the connections between the hippocampus and cortex through repetitive transcranial magnetic stimulation (TMS) may help the storage of new memories. TMS delivers painless magnetic pulses to a particular region of the brain, changing the activity of the neurons within the targeted area.

To determine whether TMS could improve memory, 15 healthy adults over the age of 64 received TMS to a part of the cortex that communicates with the hippocampus. Treatment lasted for five days. During a separate week, each participant received five days of sham treatment, in which the setup was the same, but the stimulation was too low to influence the neural connections. Before and after each five-day session, participants were asked to remember pictures of everyday objects and pictures of outdoor scenes associated with each one. The adults’ ability to recall the scenes associated with the objects improved after receiving TMS, but not after the sham treatment.

“Our study demonstrates that TMS could potentially be used as a way to improve memory for older adults experiencing age-related memory impairments,” said John A. Walker, PhD, postdoctorate fellow at Northwestern University in Evanston, Illinois. “TMS can be used to probe the relationship between brain networks and memory experimentally, opening new doors to understanding the network basis of cognitive decline in aging.”

Heading the Ball Hurts Women More Than Men

Intentionally hitting a soccer ball with the head, or “heading,” may have more adverse brain consequences for women than men, said researchers.

Heading does not typically result in a concussion, yet growing evidence links the move to CNS damage. Previous studies using diffusion tensor imaging (DTI) have revealed that heading damages the integrity of the axons. Women appear to be more vulnerable than men to problems associated with heading, as they report more symptoms that last longer, but the reason for these gender differences remains unknown.

To assess possible gender differences in the effects of heading, researchers used DTI to examine 49 male and 49 female amateur soccer players who were matched on age and frequency of heading. Higher levels of heading were associated with decreased axonal integrity in three brain regions for men and eight brain regions for women. In seven of the areas identified in women, the association between axonal integrity and heading was significantly stronger than it was in men.

“Given similar amounts of exposure to heading, women show a greater volume of abnormality that is significantly different from what is seen in men,” said lead author Todd G. Rubin, MD, a doctoral student at Albert Einstein College of Medicine in Bronx, New York. “Identifying and understanding the basis for differences in susceptibility to injury represent key steps in determining better treatments and guidelines for safer play.”

DBS Can Individualize Treatment for Parkinson’s Disease

A new approach to deep brain stimulation (DBS) adjusts itself to deliver the appropriate amount of stimulation in patients with Parkinson’s disease, according to new research. The approach could improve symptom management and reduce side effects.

DBS has been a valuable treatment for Parkinson’s disease by helping to quell the abnormal movements that are characteristic of the disease. Traditional DBS delivers a constant level of stimulation and cannot adapt if a patient’s symptoms vary over the course of a day. As a result, a patient may sometimes receive too little stimulation, which fails to control symptoms, or too much, which causes side effects such as dyskinesia.

To match stimulation to variations in patient symptoms throughout the day, researchers and engineers developed a novel implantable device that provides DBS and records activity from the surface of the brain. Similar to a cardiac pacemaker, this adaptive device can autoadjust its level of stimulation based on a physiologic signal—in this case, brain activity related to dyskinesia. A high dyskinesia signal indicated greater likelihood of unwanted side effects and caused the device to reduce the stimulation level. A low signal indicated a higher chance of symptoms returning and triggered an increase in stimulation.

The device was tested in two patients inside and outside of the laboratory. Neither patient reported discomfort, adverse events, or worsening symptoms. In addition, the battery used as much as 45% less energy than traditional DBS, which is an important advantage, since battery replacement requires surgery.

“Our study showed that totally implanted, adaptive DBS is feasible and can be used at home in patients,” said lead author Nicole C. Swann, PhD, Assistant Professor of Human Physiology at the University of Oregon in Eugene. “Adaptive stimulation represents one of the first major advances in DBS technology since this technique was first introduced for the treatment of Parkinson’s disease 25 years ago.”

 

 

Contact Sports May Impair Memory Temporarily

Sports-related head injuries may prevent the generation of new neurons in a brain region important for memory, said investigators.

Concussion can lead to cognitive impairments, and recent evidence indicates that subconcussive hits can cause damage. The hippocampus is particularly vulnerable. One way to test the effects of head impacts on the hippocampus is a memory assessment called the mnemonic similarity test (MST), which evaluates a person’s ability to distinguish between images that are novel, previously presented, or similar to images previously presented. Accumulating evidence suggests that MST scores are related to the hippocampus’s ability to generate new neurons.

To investigate changes in memory following sports-related head injuries, researchers assessed different types of athletes in two studies. In the first study, they compared athletes with concussion, uninjured athletes who played the same sport, same-sport athletes with musculoskeletal injuries, and healthy controls. Compared with the other three groups, concussed athletes performed worse on the MST when tested two to four weeks after their injury. The scores did not remain low, however. By the time the athletes were cleared to play, their scores had improved to normal levels.

In the second study, rugby players were given the MST before the season started, halfway through the season, and one month after their last game. Scores dropped midseason, compared with preseason scores, but recovered by the postseason assessment.

“Using a cognitive test believed to be sensitive to hippocampal neurogenesis, we found that athletes with concussion show impairments that resolve following recovery,” said lead author Melissa Danielle McCradden, PhD, a postdoctoral fellow at McMaster University in Toronto. “These findings represent, to the best of our knowledge, the first reported evidence in humans suggesting a brain change that might explain the cognitive and emotional symptoms associated with mild traumatic brain injury.”

Disrupted Brain Networks May Cause Gulf War Illness

The brains of veterans with Gulf War illness (GWI) show widespread communication abnormalities in networks that support various brain functions, researchers reported. The observed patterns of impairment provide objective neurophysiologic evidence to support the self-reported symptoms of veterans with GWI.

As many as 250,000 veterans who served in Iraq, Kuwait, and Saudi Arabia during the 1991 Gulf War may currently experience GWI. Symptoms include difficulty remembering things, trouble finding words while speaking, motor coordination, mood swings, fatigue, and chronic pain. GWI is thought to result from exposure to a mix of chemical and biological warfare agents and hazardous chemicals.

To better understand brain changes in GWI, researchers compared the brains of 22 veterans with GWI to the brains of 30 healthy veterans of similar age. Using resting state functional MRI, researchers analyzed patterns of communication among regions of the brain known to control different functions and behavior. They identified changes in functional networks related to many commonly reported GWI symptoms. Individuals with GWI showed clear deficits in neural communication in the sectors of the brain responsible for visual processing, mood regulation, motor coordination, sensory processing, and language command, but increased communication in networks related to pain perception during rest.

“The results from this study provide strong evidence of neuropathology in GWI patients from exposures to neurotoxic agents,” said lead author Kaundinya Gopinath, PhD, Assistant Professor of Radiology and Imaging Sciences at Emory University in Atlanta. Next, “the aim is to establish brain mechanisms underlying GWI, which in turn can lead to development of treatments.”

Prolonged Sedation May Cause Brain Abnormalities in Infants

Full-term infants who undergo repeated anesthesia and prolonged sedation are at risk for changes in brain development, according to investigators.

Developmental impacts of prenatal exposure to sedatives have been studied widely, but less is known about the immediate and long-term neurologic and developmental effects of prolonged sedation when administered to critically ill infants after birth. Prolonged administration of opioids and benzodiazepines, which commonly are used for infants undergoing surgery, is associated with a high incidence of drug tolerance and dependence. Although negative long-term outcomes have been associated with such drug exposures in infants, these studies could not exclude other possible causes, such as prematurity or heart problems.

To study neurologic effects of prolonged sedation, researchers conducted MRI scans on full-term infants who underwent life-saving surgery that required prolonged exposure to morphine and midazolam before one year of age. Brain imaging showed several brain MRI anomalies that were not present in healthy infants, including abnormalities in gray and white matter structures and the ventricles. The number of brain MRI abnormalities significantly correlated with the average daily dose of these sedative drugs. The higher the daily dose, the more MRI irregularities were seen. The patients also had more brain fluid and a smaller total brain volume, compared with healthy infants. This pattern has been associated with long-term neurodevelopmental outcomes such as autism spectrum disorder. Taken together, these preliminary findings indicate a potential negative impact of prolonged sedation on brain growth during the first year of life, the researchers said.

“We were surprised to find higher incidence of brain abnormalities in full-term infants who underwent life-saving surgery that required prolonged sedation,” said senior author Dusica Bajic, MD, PhD, Principal Investigator at Boston Children’s Hospital. “The constellation of MRI irregularities suggests prolonged sedation may potentially contribute to delayed brain growth.” Future investigations will explore the neural mechanisms of the observed developmental effects and whether early sedation exposure may lead to long-term neurobehavioral impacts.

 

 

The Brain Preferentially Reactivates Negative Memories During Sleep

The brain selectively reactivates negative memories during sleep, prioritizing the retention of these emotional memories, which may be of greater future relevance than neutral memories and thus more worth remembering, according to investigators.

Over the past two decades, neuroscientists have gained increased understanding of how sleep boosts and stabilizes memories in the human brain. In the current study, researchers presented 57 healthy volunteers with a series of neutral and negative images. While staring straight ahead, the volunteers saw all of the negative images on one side of their field of vision (left) and all of the neutral images on the other side (right). Because the brain processes visual information in the opposite hemisphere from where it is viewed, this method allowed researchers to “tag” one hemisphere with negative content and the other with neutral content, thus enabling them to track localized memories. Participants were then shown the previously seen images for memory tests, with some of the images shown immediately after the learning phase and the rest shown after a period of wakefulness or sleep. During all memory tests, volunteers viewed the images directly in front of them, rather than to either side, and researchers asked participants to state whether an image had originally appeared to the left or right.

Participants who stayed awake in between memory tests forgot some of the original image locations, but forgetting was similar for neutral and negative images. Participants who slept between tests, on the other hand, had a much better rate of recall for the negative images than for the neutral ones. EEG recordings made during the learning phase show that the brain has encoded the distinct types of memories in its two hemispheres, with the negative images strongly encoded in the hemisphere opposite to the side of presentation. Researchers are now analyzing data that they hypothesize will show that the waking EEG pattern corresponding to emotional memories is the same pattern that is reactivated most strongly during sleep.

“This [finding] would provide a long sought-after brain-based explanation of how sleep selectively stabilizes emotional memories,” said lead author Roy Cox, PhD, research fellow in psychiatry at Beth Israel Deaconess Medical Center in Boston. “Our research substantially advances the notion that sleep plays a fundamental and complex role in the offline reorganization of waking experiences.”

Issue
Neurology Reviews - 26(2)
Issue
Neurology Reviews - 26(2)
Page Number
64-65
Page Number
64-65
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default

Know risk factors for ischemic colitis after AAA repair

Article Type
Changed

 

EXPERT ANALYSIS FROM THE NORTHWESTERN VASCULAR SYMPOSIUM

– Postoperative ischemic colitis after abdominal aortic aneurysm (AAA) repair is a feared, potentially devastating complication with a mortality approaching 50%, but early diagnosis can mitigate that risk, Roy M. Fujitani, MD, said at a symposium on vascular surgery sponsored by Northwestern University in Chicago.

Bruce Jancin/Frontline Medical News
Dr. Roy M. Fujitani
The key is to be familiar with the risk factors for this complication. Close surveillance of patients with multiple risk factors is particularly important for the first 4 days after AAA repair since more than three-quarters of cases are diagnosed in this time frame, according to Dr. Fujitani, professor and vice chair of surgery at University of California, Irvine.

The most common etiology of ischemic colitis following AAA repair is hypoperfusion of the mesenteric vasculature leading to nonocclusive ischemia. Caught early – in the initial hyperactive phase of colonic ischemia – the complication is typically transient and can be managed medically without further sequelae. Improvement is generally noted within a day or 2, with complete resolution within 1-2 weeks.

The earliest indicator that a patient is in the hyperactive phase of ischemic colitis following completion of an AAA repair can be defecation while still on the operating table.

“When you’ve just completed an operation and the patient has a bowel movement right on the operating table, that always makes me very, very concerned because of the likelihood of an associated ischemic colitis,” the surgeon noted.

A conscious patient in the first phase of ischemic colitis will describe an urgent desire to defecate, along with crampy pain and loose bowel movements with or without blood in the stool.

In the second, paralytic phase of ischemic colitis, the pain diminishes in intensity but becomes more continuous and diffuse, usually in the lateral borders of the abdomen. The abdomen becomes distended and much more tender, and there are no bowel sounds.

In patients whose ischemic colitis has been misdiagnosed or undiagnosed, the shock phase comes next. This is marked by massive fluid, protein, and electrolyte loss through the gangrenous mucosa. The result is severe dehydration, metabolic acidosis, and hypovolemic shock.

Nonocclusive colonic ischemia most often affects the watershed areas of the colon, such as the Sudeck point at the rectosigmoid junction.

The two other etiologies of ischemic colitis occurring as a complication of AAA repair are acute arterial occlusion, typically caused by iatrogenic embolization from a proximal source, often during endovascular aneurysm repair (EVAR), or rarely, venous thrombosis.
 

Making the diagnosis

When a patient is suspected of having ischemic colitis, one of the easiest ways of advancing toward a diagnosis is to obtain an abdominal plain x-ray, which classically shows thumb printing indicative of submucosal edema. CT with IV contrast typically shows bowel wall thickening, pericolonic fat stranding, and – most significantly – there may be free air within the colonic wall, an indicator of more advanced ischemia that occurs shortly before transmural gangrenous changes.

Colonoscopy is, however, the mainstay of diagnosis. It should be performed in any patient where postoperative ischemic colitis is suspected.
 

Ischemic colitis risk factors and outcomes

Dr. Fujitani was senior author of the largest ever study of risk factors for and outcomes of postoperative ischemic colitis in patients undergoing contemporary methods of open and endovascular AAA repair. This retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database included 3,486 patients who underwent AAA repair in U.S. hospitals during 2011-2012. Twelve percent had an open repair, while the other 88% underwent EVAR.

The incidence of postoperative ischemic colitis was 2.2%. The median time of diagnosis was on postoperative day 2. The rate was nearly threefold higher in the open repair group: 5.2% versus 1.8%. However, the open-repair group had a higher rate of emergency admission, ruptured aneurysm before surgery, and other high-risk features. Upon multivariate analysis, the adjusted risk of postoperative ischemic colitis was no longer significantly different in the open-repair and EVAR groups.

The mean hospital length of stay in patients with postoperative ischemic colitis was 20 days, compared with 5 days in those without the complication. The unadjusted in-hospital mortality rate in patients with ischemic colitis was 39% versus 4% in those without ischemic colitis.

Of the 75 patients who developed postoperative ischemic colitis, 37 were managed medically, 38 surgically.

“What was quite surprising was that there was a 56.8% in-hospital mortality in the surgically treated patients. The point being that if you end up having ischemic colitis, there’s a 50% chance you’ll end up requiring an operation, and if you do undergo an operation you have more than a 50% chance of succumbing from the process,” Dr. Fujitani observed.

Dr. Fujitani and his coinvestigators scrutinized a plethora of potential risk factors for postoperative ischemic colitis. Six emerged as significant upon multivariate analysis: ruptured aneurysm before surgery, with an associated adjusted 4.1-fold increased risk; need for intra- or postoperative transfusion, with a 6-fold increased risk; renal failure requiring dialysis, with a 3.9-fold risk; proximal extension of the aneurysm, with a 2.2-fold elevation in risk; diabetes, with a 1.9-fold risk; and female sex, with an adjusted 1.75-fold increased risk (J Vasc Surg. 2016 Apr;63[4]:866-72).

Of note, these risk factors are largely unmodifiable, which underscores the importance of vigorous surveillance for possible signs of ischemic colitis during the first 4 days after AAA repair, especially in patients with multiple risk factors, Dr. Fujitani said.

Also, careful intraoperative assessment of the collateral mesenteric vascular anatomy is important in assessing a patient’s risk for postoperative ischemic colitis. This assessment should include the superior and inferior mesenteric arteries, as well as the celiac and internal iliac arteries. It’s worth bearing in mind that, even though collateral flow may appear adequate, it can be affected by hypovolemia, hypotension, or low cardiac output, the surgeon continued.

In the NSQIP data analysis, no patients who underwent reimplantation of the inferior mesenteric artery during open repair developed postoperative ischemic colitis. While this is an encouraging finding, the numbers were too small to draw definitive conclusions as to whether reimplantation of the artery is protective. It’s an important issue for further study, though, since so few of the recognized risk factors for the complication are modifiable, Dr. Fujitani noted.

He reported having no financial conflicts regarding his presentation.

 

Meeting/Event
Publications
Topics
Sections
Meeting/Event
Meeting/Event

 

EXPERT ANALYSIS FROM THE NORTHWESTERN VASCULAR SYMPOSIUM

– Postoperative ischemic colitis after abdominal aortic aneurysm (AAA) repair is a feared, potentially devastating complication with a mortality approaching 50%, but early diagnosis can mitigate that risk, Roy M. Fujitani, MD, said at a symposium on vascular surgery sponsored by Northwestern University in Chicago.

Bruce Jancin/Frontline Medical News
Dr. Roy M. Fujitani
The key is to be familiar with the risk factors for this complication. Close surveillance of patients with multiple risk factors is particularly important for the first 4 days after AAA repair since more than three-quarters of cases are diagnosed in this time frame, according to Dr. Fujitani, professor and vice chair of surgery at University of California, Irvine.

The most common etiology of ischemic colitis following AAA repair is hypoperfusion of the mesenteric vasculature leading to nonocclusive ischemia. Caught early – in the initial hyperactive phase of colonic ischemia – the complication is typically transient and can be managed medically without further sequelae. Improvement is generally noted within a day or 2, with complete resolution within 1-2 weeks.

The earliest indicator that a patient is in the hyperactive phase of ischemic colitis following completion of an AAA repair can be defecation while still on the operating table.

“When you’ve just completed an operation and the patient has a bowel movement right on the operating table, that always makes me very, very concerned because of the likelihood of an associated ischemic colitis,” the surgeon noted.

A conscious patient in the first phase of ischemic colitis will describe an urgent desire to defecate, along with crampy pain and loose bowel movements with or without blood in the stool.

In the second, paralytic phase of ischemic colitis, the pain diminishes in intensity but becomes more continuous and diffuse, usually in the lateral borders of the abdomen. The abdomen becomes distended and much more tender, and there are no bowel sounds.

In patients whose ischemic colitis has been misdiagnosed or undiagnosed, the shock phase comes next. This is marked by massive fluid, protein, and electrolyte loss through the gangrenous mucosa. The result is severe dehydration, metabolic acidosis, and hypovolemic shock.

Nonocclusive colonic ischemia most often affects the watershed areas of the colon, such as the Sudeck point at the rectosigmoid junction.

The two other etiologies of ischemic colitis occurring as a complication of AAA repair are acute arterial occlusion, typically caused by iatrogenic embolization from a proximal source, often during endovascular aneurysm repair (EVAR), or rarely, venous thrombosis.
 

Making the diagnosis

When a patient is suspected of having ischemic colitis, one of the easiest ways of advancing toward a diagnosis is to obtain an abdominal plain x-ray, which classically shows thumb printing indicative of submucosal edema. CT with IV contrast typically shows bowel wall thickening, pericolonic fat stranding, and – most significantly – there may be free air within the colonic wall, an indicator of more advanced ischemia that occurs shortly before transmural gangrenous changes.

Colonoscopy is, however, the mainstay of diagnosis. It should be performed in any patient where postoperative ischemic colitis is suspected.
 

Ischemic colitis risk factors and outcomes

Dr. Fujitani was senior author of the largest ever study of risk factors for and outcomes of postoperative ischemic colitis in patients undergoing contemporary methods of open and endovascular AAA repair. This retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database included 3,486 patients who underwent AAA repair in U.S. hospitals during 2011-2012. Twelve percent had an open repair, while the other 88% underwent EVAR.

The incidence of postoperative ischemic colitis was 2.2%. The median time of diagnosis was on postoperative day 2. The rate was nearly threefold higher in the open repair group: 5.2% versus 1.8%. However, the open-repair group had a higher rate of emergency admission, ruptured aneurysm before surgery, and other high-risk features. Upon multivariate analysis, the adjusted risk of postoperative ischemic colitis was no longer significantly different in the open-repair and EVAR groups.

The mean hospital length of stay in patients with postoperative ischemic colitis was 20 days, compared with 5 days in those without the complication. The unadjusted in-hospital mortality rate in patients with ischemic colitis was 39% versus 4% in those without ischemic colitis.

Of the 75 patients who developed postoperative ischemic colitis, 37 were managed medically, 38 surgically.

“What was quite surprising was that there was a 56.8% in-hospital mortality in the surgically treated patients. The point being that if you end up having ischemic colitis, there’s a 50% chance you’ll end up requiring an operation, and if you do undergo an operation you have more than a 50% chance of succumbing from the process,” Dr. Fujitani observed.

Dr. Fujitani and his coinvestigators scrutinized a plethora of potential risk factors for postoperative ischemic colitis. Six emerged as significant upon multivariate analysis: ruptured aneurysm before surgery, with an associated adjusted 4.1-fold increased risk; need for intra- or postoperative transfusion, with a 6-fold increased risk; renal failure requiring dialysis, with a 3.9-fold risk; proximal extension of the aneurysm, with a 2.2-fold elevation in risk; diabetes, with a 1.9-fold risk; and female sex, with an adjusted 1.75-fold increased risk (J Vasc Surg. 2016 Apr;63[4]:866-72).

Of note, these risk factors are largely unmodifiable, which underscores the importance of vigorous surveillance for possible signs of ischemic colitis during the first 4 days after AAA repair, especially in patients with multiple risk factors, Dr. Fujitani said.

Also, careful intraoperative assessment of the collateral mesenteric vascular anatomy is important in assessing a patient’s risk for postoperative ischemic colitis. This assessment should include the superior and inferior mesenteric arteries, as well as the celiac and internal iliac arteries. It’s worth bearing in mind that, even though collateral flow may appear adequate, it can be affected by hypovolemia, hypotension, or low cardiac output, the surgeon continued.

In the NSQIP data analysis, no patients who underwent reimplantation of the inferior mesenteric artery during open repair developed postoperative ischemic colitis. While this is an encouraging finding, the numbers were too small to draw definitive conclusions as to whether reimplantation of the artery is protective. It’s an important issue for further study, though, since so few of the recognized risk factors for the complication are modifiable, Dr. Fujitani noted.

He reported having no financial conflicts regarding his presentation.

 

 

EXPERT ANALYSIS FROM THE NORTHWESTERN VASCULAR SYMPOSIUM

– Postoperative ischemic colitis after abdominal aortic aneurysm (AAA) repair is a feared, potentially devastating complication with a mortality approaching 50%, but early diagnosis can mitigate that risk, Roy M. Fujitani, MD, said at a symposium on vascular surgery sponsored by Northwestern University in Chicago.

Bruce Jancin/Frontline Medical News
Dr. Roy M. Fujitani
The key is to be familiar with the risk factors for this complication. Close surveillance of patients with multiple risk factors is particularly important for the first 4 days after AAA repair since more than three-quarters of cases are diagnosed in this time frame, according to Dr. Fujitani, professor and vice chair of surgery at University of California, Irvine.

The most common etiology of ischemic colitis following AAA repair is hypoperfusion of the mesenteric vasculature leading to nonocclusive ischemia. Caught early – in the initial hyperactive phase of colonic ischemia – the complication is typically transient and can be managed medically without further sequelae. Improvement is generally noted within a day or 2, with complete resolution within 1-2 weeks.

The earliest indicator that a patient is in the hyperactive phase of ischemic colitis following completion of an AAA repair can be defecation while still on the operating table.

“When you’ve just completed an operation and the patient has a bowel movement right on the operating table, that always makes me very, very concerned because of the likelihood of an associated ischemic colitis,” the surgeon noted.

A conscious patient in the first phase of ischemic colitis will describe an urgent desire to defecate, along with crampy pain and loose bowel movements with or without blood in the stool.

In the second, paralytic phase of ischemic colitis, the pain diminishes in intensity but becomes more continuous and diffuse, usually in the lateral borders of the abdomen. The abdomen becomes distended and much more tender, and there are no bowel sounds.

In patients whose ischemic colitis has been misdiagnosed or undiagnosed, the shock phase comes next. This is marked by massive fluid, protein, and electrolyte loss through the gangrenous mucosa. The result is severe dehydration, metabolic acidosis, and hypovolemic shock.

Nonocclusive colonic ischemia most often affects the watershed areas of the colon, such as the Sudeck point at the rectosigmoid junction.

The two other etiologies of ischemic colitis occurring as a complication of AAA repair are acute arterial occlusion, typically caused by iatrogenic embolization from a proximal source, often during endovascular aneurysm repair (EVAR), or rarely, venous thrombosis.
 

Making the diagnosis

When a patient is suspected of having ischemic colitis, one of the easiest ways of advancing toward a diagnosis is to obtain an abdominal plain x-ray, which classically shows thumb printing indicative of submucosal edema. CT with IV contrast typically shows bowel wall thickening, pericolonic fat stranding, and – most significantly – there may be free air within the colonic wall, an indicator of more advanced ischemia that occurs shortly before transmural gangrenous changes.

Colonoscopy is, however, the mainstay of diagnosis. It should be performed in any patient where postoperative ischemic colitis is suspected.
 

Ischemic colitis risk factors and outcomes

Dr. Fujitani was senior author of the largest ever study of risk factors for and outcomes of postoperative ischemic colitis in patients undergoing contemporary methods of open and endovascular AAA repair. This retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database included 3,486 patients who underwent AAA repair in U.S. hospitals during 2011-2012. Twelve percent had an open repair, while the other 88% underwent EVAR.

The incidence of postoperative ischemic colitis was 2.2%. The median time of diagnosis was on postoperative day 2. The rate was nearly threefold higher in the open repair group: 5.2% versus 1.8%. However, the open-repair group had a higher rate of emergency admission, ruptured aneurysm before surgery, and other high-risk features. Upon multivariate analysis, the adjusted risk of postoperative ischemic colitis was no longer significantly different in the open-repair and EVAR groups.

The mean hospital length of stay in patients with postoperative ischemic colitis was 20 days, compared with 5 days in those without the complication. The unadjusted in-hospital mortality rate in patients with ischemic colitis was 39% versus 4% in those without ischemic colitis.

Of the 75 patients who developed postoperative ischemic colitis, 37 were managed medically, 38 surgically.

“What was quite surprising was that there was a 56.8% in-hospital mortality in the surgically treated patients. The point being that if you end up having ischemic colitis, there’s a 50% chance you’ll end up requiring an operation, and if you do undergo an operation you have more than a 50% chance of succumbing from the process,” Dr. Fujitani observed.

Dr. Fujitani and his coinvestigators scrutinized a plethora of potential risk factors for postoperative ischemic colitis. Six emerged as significant upon multivariate analysis: ruptured aneurysm before surgery, with an associated adjusted 4.1-fold increased risk; need for intra- or postoperative transfusion, with a 6-fold increased risk; renal failure requiring dialysis, with a 3.9-fold risk; proximal extension of the aneurysm, with a 2.2-fold elevation in risk; diabetes, with a 1.9-fold risk; and female sex, with an adjusted 1.75-fold increased risk (J Vasc Surg. 2016 Apr;63[4]:866-72).

Of note, these risk factors are largely unmodifiable, which underscores the importance of vigorous surveillance for possible signs of ischemic colitis during the first 4 days after AAA repair, especially in patients with multiple risk factors, Dr. Fujitani said.

Also, careful intraoperative assessment of the collateral mesenteric vascular anatomy is important in assessing a patient’s risk for postoperative ischemic colitis. This assessment should include the superior and inferior mesenteric arteries, as well as the celiac and internal iliac arteries. It’s worth bearing in mind that, even though collateral flow may appear adequate, it can be affected by hypovolemia, hypotension, or low cardiac output, the surgeon continued.

In the NSQIP data analysis, no patients who underwent reimplantation of the inferior mesenteric artery during open repair developed postoperative ischemic colitis. While this is an encouraging finding, the numbers were too small to draw definitive conclusions as to whether reimplantation of the artery is protective. It’s an important issue for further study, though, since so few of the recognized risk factors for the complication are modifiable, Dr. Fujitani noted.

He reported having no financial conflicts regarding his presentation.

 

Publications
Publications
Topics
Article Type
Click for Credit Status
Ready
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default

Lipid variability predicts cardiovascular events, diabetes onset

Article Type
Changed

 

ANAHEIM, CALIF.Variability in fasting lipid levels over time in statin-treated patients is of prognostic importance, David D. Waters, MD, reported at the American Heart Association scientific sessions.

More specifically, above-average visit-to-visit variability in fasting triglycerides, LDL cholesterol, or HDL cholesterol in atorvastatin-treated patients with known coronary artery disease proved to be a strong and independent predictor of coronary and cardiovascular events in a post hoc analysis of the landmark Treating to New Targets (TNT) trial (N Engl J Med 2005;352:1425-35).

Bruce Jancin/Frontline Medical News
Dr. David D. Waters
Also, high variability in triglyceride and LDL cholesterol levels – but not HDL cholesterol – independently predicted new-onset diabetes, added Dr. Waters, emeritus professor of medicine at the University of California, San Francisco.

The TNT trial randomized more than 10,000 subjects with known coronary artery disease and a baseline LDL cholesterol level below 130 mg/dL to receive either 10 or 80 mg/day of atorvastatin, with fasting lipids measured in a central laboratory at 3 and 12 months, then annually. The trial demonstrated that high-intensity statin therapy was more effective at preventing cardiovascular events than moderate-intensity therapy, thereby ushering in major changes in clinical practice guidelines.

The TNT investigators had previously reported that higher visit-to-visit variability in LDL cholesterol was independently associated with an increased rate of cardiovascular events during the median 4.9 years of study follow-up. In a multivariate regression analysis, each 1 standard deviation increase in average successive variability – that is, the average absolute difference between successive LDL cholesterol values – was associated with a 16% increase in the risk of any coronary event, an 11% increase in risk of any cardiovascular event, a 10% increase in MI, an 17% increase in stroke, and a 23% higher all-cause mortality independent of assignment treatment, achieved LDL cholesterol, demographics, and baseline cardiovascular risk factors.

At the AHA meeting in Anaheim, Dr. Waters presented an expanded analysis of 9,572 TNT participants that incorporated visit-to-visit variability in HDL cholesterol and triglycerides (J Am Coll Cardiol. 2015 Apr 21;65[15]:1539-48). Patients with 1 standard deviation of average successive variability (ASV) in triglycerides – that is, more than 30 mg/dL of visit-to-visit variability – had a 9% increased risk of coronary events during follow-up in a multivariate analysis. Patients with more than 4 mg/dL of variability in HDL cholesterol had a 16% increased risk compared with those with lesser variability.

“For both coronary and cardiovascular events, most of the increased risk appears to reside in the uppermost quintile,” the cardiologist observed.

Indeed, when the investigators divided patients into quintiles of ASV, the top quintile in terms of triglyceride variability had a 34% greater risk of coronary events, a 31% increase in risk of cardiovascular events, a 63% increase in stroke, a 65% increase in nonfatal MI, and a 92% greater likelihood of new-onset diabetes compared with patients in the lowest quintile of ASV. In contrast, these risks were not significantly elevated in the second, third, and fourth quintiles.

Similarly, patients in the top quintile for HDL cholesterol ASV had a 50% greater rate of coronary events, a 56% increased risk of cardiovascular events, a 70% increase in stroke, and a 61% increase in nonfatal MI, compared with those in the lowest quintile. Again, risks weren’t significantly increased in the second through fourth quintiles. Unlike with triglycerides, greater variability in fasting HDL cholesterol over time wasn’t predictive of new-onset diabetes.

Observers noted that these findings could be clinically relevant for patients who remain at high residual risk for atherosclerotic cardiovascular events even after aggressive LDL cholesterol lowering.

Variability in levels of the three lipids was only weakly correlated.

Dr. Waters made a plea to his audience, “The mechanisms accounting for these associations are unknown. If you can suggest for me any possibility of what the causes are, I’d be very happy to hear it and go back to try to verify it.”

He reported serving as a consultant to Resverlogix, CSL Limited, the Medicines Company, Pfizer, and Sanofi-Aventis.
 
Meeting/Event
Publications
Topics
Sections
Meeting/Event
Meeting/Event

 

ANAHEIM, CALIF.Variability in fasting lipid levels over time in statin-treated patients is of prognostic importance, David D. Waters, MD, reported at the American Heart Association scientific sessions.

More specifically, above-average visit-to-visit variability in fasting triglycerides, LDL cholesterol, or HDL cholesterol in atorvastatin-treated patients with known coronary artery disease proved to be a strong and independent predictor of coronary and cardiovascular events in a post hoc analysis of the landmark Treating to New Targets (TNT) trial (N Engl J Med 2005;352:1425-35).

Bruce Jancin/Frontline Medical News
Dr. David D. Waters
Also, high variability in triglyceride and LDL cholesterol levels – but not HDL cholesterol – independently predicted new-onset diabetes, added Dr. Waters, emeritus professor of medicine at the University of California, San Francisco.

The TNT trial randomized more than 10,000 subjects with known coronary artery disease and a baseline LDL cholesterol level below 130 mg/dL to receive either 10 or 80 mg/day of atorvastatin, with fasting lipids measured in a central laboratory at 3 and 12 months, then annually. The trial demonstrated that high-intensity statin therapy was more effective at preventing cardiovascular events than moderate-intensity therapy, thereby ushering in major changes in clinical practice guidelines.

The TNT investigators had previously reported that higher visit-to-visit variability in LDL cholesterol was independently associated with an increased rate of cardiovascular events during the median 4.9 years of study follow-up. In a multivariate regression analysis, each 1 standard deviation increase in average successive variability – that is, the average absolute difference between successive LDL cholesterol values – was associated with a 16% increase in the risk of any coronary event, an 11% increase in risk of any cardiovascular event, a 10% increase in MI, an 17% increase in stroke, and a 23% higher all-cause mortality independent of assignment treatment, achieved LDL cholesterol, demographics, and baseline cardiovascular risk factors.

At the AHA meeting in Anaheim, Dr. Waters presented an expanded analysis of 9,572 TNT participants that incorporated visit-to-visit variability in HDL cholesterol and triglycerides (J Am Coll Cardiol. 2015 Apr 21;65[15]:1539-48). Patients with 1 standard deviation of average successive variability (ASV) in triglycerides – that is, more than 30 mg/dL of visit-to-visit variability – had a 9% increased risk of coronary events during follow-up in a multivariate analysis. Patients with more than 4 mg/dL of variability in HDL cholesterol had a 16% increased risk compared with those with lesser variability.

“For both coronary and cardiovascular events, most of the increased risk appears to reside in the uppermost quintile,” the cardiologist observed.

Indeed, when the investigators divided patients into quintiles of ASV, the top quintile in terms of triglyceride variability had a 34% greater risk of coronary events, a 31% increase in risk of cardiovascular events, a 63% increase in stroke, a 65% increase in nonfatal MI, and a 92% greater likelihood of new-onset diabetes compared with patients in the lowest quintile of ASV. In contrast, these risks were not significantly elevated in the second, third, and fourth quintiles.

Similarly, patients in the top quintile for HDL cholesterol ASV had a 50% greater rate of coronary events, a 56% increased risk of cardiovascular events, a 70% increase in stroke, and a 61% increase in nonfatal MI, compared with those in the lowest quintile. Again, risks weren’t significantly increased in the second through fourth quintiles. Unlike with triglycerides, greater variability in fasting HDL cholesterol over time wasn’t predictive of new-onset diabetes.

Observers noted that these findings could be clinically relevant for patients who remain at high residual risk for atherosclerotic cardiovascular events even after aggressive LDL cholesterol lowering.

Variability in levels of the three lipids was only weakly correlated.

Dr. Waters made a plea to his audience, “The mechanisms accounting for these associations are unknown. If you can suggest for me any possibility of what the causes are, I’d be very happy to hear it and go back to try to verify it.”

He reported serving as a consultant to Resverlogix, CSL Limited, the Medicines Company, Pfizer, and Sanofi-Aventis.
 

 

ANAHEIM, CALIF.Variability in fasting lipid levels over time in statin-treated patients is of prognostic importance, David D. Waters, MD, reported at the American Heart Association scientific sessions.

More specifically, above-average visit-to-visit variability in fasting triglycerides, LDL cholesterol, or HDL cholesterol in atorvastatin-treated patients with known coronary artery disease proved to be a strong and independent predictor of coronary and cardiovascular events in a post hoc analysis of the landmark Treating to New Targets (TNT) trial (N Engl J Med 2005;352:1425-35).

Bruce Jancin/Frontline Medical News
Dr. David D. Waters
Also, high variability in triglyceride and LDL cholesterol levels – but not HDL cholesterol – independently predicted new-onset diabetes, added Dr. Waters, emeritus professor of medicine at the University of California, San Francisco.

The TNT trial randomized more than 10,000 subjects with known coronary artery disease and a baseline LDL cholesterol level below 130 mg/dL to receive either 10 or 80 mg/day of atorvastatin, with fasting lipids measured in a central laboratory at 3 and 12 months, then annually. The trial demonstrated that high-intensity statin therapy was more effective at preventing cardiovascular events than moderate-intensity therapy, thereby ushering in major changes in clinical practice guidelines.

The TNT investigators had previously reported that higher visit-to-visit variability in LDL cholesterol was independently associated with an increased rate of cardiovascular events during the median 4.9 years of study follow-up. In a multivariate regression analysis, each 1 standard deviation increase in average successive variability – that is, the average absolute difference between successive LDL cholesterol values – was associated with a 16% increase in the risk of any coronary event, an 11% increase in risk of any cardiovascular event, a 10% increase in MI, an 17% increase in stroke, and a 23% higher all-cause mortality independent of assignment treatment, achieved LDL cholesterol, demographics, and baseline cardiovascular risk factors.

At the AHA meeting in Anaheim, Dr. Waters presented an expanded analysis of 9,572 TNT participants that incorporated visit-to-visit variability in HDL cholesterol and triglycerides (J Am Coll Cardiol. 2015 Apr 21;65[15]:1539-48). Patients with 1 standard deviation of average successive variability (ASV) in triglycerides – that is, more than 30 mg/dL of visit-to-visit variability – had a 9% increased risk of coronary events during follow-up in a multivariate analysis. Patients with more than 4 mg/dL of variability in HDL cholesterol had a 16% increased risk compared with those with lesser variability.

“For both coronary and cardiovascular events, most of the increased risk appears to reside in the uppermost quintile,” the cardiologist observed.

Indeed, when the investigators divided patients into quintiles of ASV, the top quintile in terms of triglyceride variability had a 34% greater risk of coronary events, a 31% increase in risk of cardiovascular events, a 63% increase in stroke, a 65% increase in nonfatal MI, and a 92% greater likelihood of new-onset diabetes compared with patients in the lowest quintile of ASV. In contrast, these risks were not significantly elevated in the second, third, and fourth quintiles.

Similarly, patients in the top quintile for HDL cholesterol ASV had a 50% greater rate of coronary events, a 56% increased risk of cardiovascular events, a 70% increase in stroke, and a 61% increase in nonfatal MI, compared with those in the lowest quintile. Again, risks weren’t significantly increased in the second through fourth quintiles. Unlike with triglycerides, greater variability in fasting HDL cholesterol over time wasn’t predictive of new-onset diabetes.

Observers noted that these findings could be clinically relevant for patients who remain at high residual risk for atherosclerotic cardiovascular events even after aggressive LDL cholesterol lowering.

Variability in levels of the three lipids was only weakly correlated.

Dr. Waters made a plea to his audience, “The mechanisms accounting for these associations are unknown. If you can suggest for me any possibility of what the causes are, I’d be very happy to hear it and go back to try to verify it.”

He reported serving as a consultant to Resverlogix, CSL Limited, the Medicines Company, Pfizer, and Sanofi-Aventis.
 
Publications
Publications
Topics
Article Type
Click for Credit Status
Ready
Sections
Article Source

REPORTING FROM THE AHA SCIENTIFIC SESSIONS

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Vitals

 

Key clinical point: Variability in fasting lipids over time in statin-treated patients is of prognostic importance.

Major finding: More than 30 mg/dL of visit-to-visit variability in triglycerides was independently associated with a 34% increase in risk of coronary events and a 31% increase in cardiovascular events.

Study details: This was a post hoc analysis of the clinical impact of visit-to-visit variability in fasting lipids in 9,572 participants in the randomized, double-blind TNT trial, all of whom were on statin therapy.

Disclosures: The presenter reported serving as a consultant to Pfizer, which sponsored the TNT trial, as well as to several other companies.

Disqus Comments
Default

FDA adds boxed warning to obeticholic acid label

Article Type
Changed

 

The Food and Drug Administration is requiring a boxed warning on the label for obeticholic acid (Ocaliva) to highlight the correct weekly dosing regimen after incorrect daily dosing caused severe liver injury in patients with moderate to severe primary biliary cholangitis (PBC).

“FDA is adding a new Boxed Warning, FDA’s most prominent warning, to highlight this information in the prescribing information of the drug label,” FDA officials said in a statement Feb. 1. “To ensure correct dosing and reduce the risk of liver problems, FDA is clarifying the current recommendations for screening, dosing, monitoring, and managing PBC patients with moderate to severe liver disease taking Ocaliva.”

The warning is an update to a Sept. 2017 MedWatch notice on the increased risk for patients from excessive dosing of obeticholic acid.

FDA recommends that “health care professionals should follow the Ocaliva dosing regimen in the drug label. … Dosing higher than recommended in the drug label can increase the risk for liver decompensation, liver failure, and sometimes death. Routinely monitor all patients for biochemical response, tolerability, and PBC progression, and reevaluate Child-Pugh classification to determine if dosage adjustment is needed.”

Manufacturer Intercept Pharmaceuticals was required to continue studying obeticholic acid in patients with advanced PBC as a condition of its FDA approval. Results from these studies are expected in 2023, FDA noted.

To report adverse medication events and side effects to the FDA, access the MedWatch program.

Publications
Topics
Sections

 

The Food and Drug Administration is requiring a boxed warning on the label for obeticholic acid (Ocaliva) to highlight the correct weekly dosing regimen after incorrect daily dosing caused severe liver injury in patients with moderate to severe primary biliary cholangitis (PBC).

“FDA is adding a new Boxed Warning, FDA’s most prominent warning, to highlight this information in the prescribing information of the drug label,” FDA officials said in a statement Feb. 1. “To ensure correct dosing and reduce the risk of liver problems, FDA is clarifying the current recommendations for screening, dosing, monitoring, and managing PBC patients with moderate to severe liver disease taking Ocaliva.”

The warning is an update to a Sept. 2017 MedWatch notice on the increased risk for patients from excessive dosing of obeticholic acid.

FDA recommends that “health care professionals should follow the Ocaliva dosing regimen in the drug label. … Dosing higher than recommended in the drug label can increase the risk for liver decompensation, liver failure, and sometimes death. Routinely monitor all patients for biochemical response, tolerability, and PBC progression, and reevaluate Child-Pugh classification to determine if dosage adjustment is needed.”

Manufacturer Intercept Pharmaceuticals was required to continue studying obeticholic acid in patients with advanced PBC as a condition of its FDA approval. Results from these studies are expected in 2023, FDA noted.

To report adverse medication events and side effects to the FDA, access the MedWatch program.

 

The Food and Drug Administration is requiring a boxed warning on the label for obeticholic acid (Ocaliva) to highlight the correct weekly dosing regimen after incorrect daily dosing caused severe liver injury in patients with moderate to severe primary biliary cholangitis (PBC).

“FDA is adding a new Boxed Warning, FDA’s most prominent warning, to highlight this information in the prescribing information of the drug label,” FDA officials said in a statement Feb. 1. “To ensure correct dosing and reduce the risk of liver problems, FDA is clarifying the current recommendations for screening, dosing, monitoring, and managing PBC patients with moderate to severe liver disease taking Ocaliva.”

The warning is an update to a Sept. 2017 MedWatch notice on the increased risk for patients from excessive dosing of obeticholic acid.

FDA recommends that “health care professionals should follow the Ocaliva dosing regimen in the drug label. … Dosing higher than recommended in the drug label can increase the risk for liver decompensation, liver failure, and sometimes death. Routinely monitor all patients for biochemical response, tolerability, and PBC progression, and reevaluate Child-Pugh classification to determine if dosage adjustment is needed.”

Manufacturer Intercept Pharmaceuticals was required to continue studying obeticholic acid in patients with advanced PBC as a condition of its FDA approval. Results from these studies are expected in 2023, FDA noted.

To report adverse medication events and side effects to the FDA, access the MedWatch program.

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default